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Abstract
Incarcerated populations are disproportionately affected by traumatic experiences and symptoms
of posttraumatic stress disorder (PTSD). Many effective treatments for PTSD utilize exposurebased techniques which require engaging with emotionally distressing content. However,
individuals with PTSD and low distress tolerance (DT) are more likely than those with PTSD
and higher DT to engage in avoidant coping behaviors and have relatively high treatment
attrition rates in general. This study explored relations between DT and treatment persistence,
engagement, and improvement in incarcerated women (N = 85) enrolled in an 8-week exposurebased sexual assault recovery group at a minimum-security prison. I hypothesized lower baseline
levels of DT would be related to lower treatment persistence and engagement with distressing
content during treatment. I also hypothesized lower baseline DT would be related to lower
treatment gains and higher levels of post-treatment symptoms of PTSD and depression. Finally, I
hypothesized completing exposure-based group therapy would be associated with increases in
DT post-treatment. Contrary to hypotheses, no significant relation was found between baseline
DT and treatment persistence. Furthermore, lower levels of baseline DT were associated with
higher levels of emotional engagement during exposure, which was the opposite of what was
predicted. Also contrary to expectations, non-linear effects were found for relations between
baseline DT and improvements in internalizing symptoms: lower levels of baseline DT were
associated with greater symptom improvement than moderate to high levels of baseline DT.
Consistent with hypotheses, DT significantly improved from pre- to post-treatment. Qualitative
analyses of respondents at post-treatment revealed concerns of dropping out related to fear of
sharing (e.g., trust violations, increased symptoms) and motivations for staying related to healing
and commitment. Themes did not vary by baseline DT. Overall, findings suggest participants

with lower baseline DT can not only benefit from exposure-based therapy, but were more
emotionally engaged in exposure and demonstrated greater internalizing symptoms improvement
than those with moderate to high baseline DT.
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Introduction
Despite evidence supporting the efficacy and effectiveness of exposure-based treatments
for posttraumatic stress disorder (PTSD; e.g, Cahill, Rothbaum, Resick, & Follette, 2009;
Rothbaum, Meadows, Resick, Foy, 2000), attrition rates are relatively high (Najavits, 2015).
Low distress tolerance (DT), operationally defined for this study as “the perceived capacity to
withstand negative emotional and/or other aversive states” (Simons & Gaher, 2005), is highly
correlated with and a risk factor for development of PTSD (e.g., Marshall-Berenz, Vujanovic,
Bonn-Miller, Bernstein, & Zvolensky, 2010). Both PTSD and low DT are implicated in avoidant
coping (Marshall-Berenz et al., 2010; Vujanovic, Litz, & Farris, 2015). This avoidance may be
problematic for participation in these highly effective treatments for PTSD, which involve
exposure. Therefore, we are interested in predicting treatment involvement and outcomes by
exploring the predictive power of DT prior to treatment.
Trauma and PTSD
Traumatic experiences are relatively prevalent and potentially problematic. National
estimates of exposure to traumatic events in the United States found 89.7% of survey
respondents endorsed traumatic event exposure consistent with criteria in the Diagnostic and
Statistical Manual of Mental Disorders – 5th Edition (DSM-5; American Psychiatric Association
[APA], 2013) and exposure to multiple traumatic event types is the norm (Kilpatrick et al.,
2013). Some people recover naturally from these experiences whereas others develop clinically
significant symptoms of traumatic stress (e.g., Breslau et al 1998; Kessler, Sonnega, Bromet,
Hughes, & Nelson, 1995; Perkonigg, Kessler, Storz, & Wittchen, 2000; Resnick, Kilpatrick,
Dansky, Saunders, & Best, 1993; Tolin & Foa, 2006). Prevalence of PTSD development in crime
victims is between 19% and 75%; however, rates up to 80% have been reported for victims of
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rape (Javidi & Yadollahie, 2012). In the general population, lifetime prevalence of PTSD is 5.7%
with a 10.1% lifetime morbid risk, including predicted future onsets (Kessler, Petukhova,
Sampson, Zaslavsky, & Wittchen, 2012). Nearly 40% of individuals with PTSD experience a
chronic course of symptoms (Santiago et al., 2013).
Rates of exposure to traumatic experiences vary both by gender and type of traumatic
exposure; for example, compared to men, women report higher rates of experiencing sexual
assault (e.g., Kessler et al., 1995; Kilpatrick et al., 2013), a traumatic event type with the highest
risk for developing PTSD compared to other trauma types (Creamer, Burgess, & McFarlane,
2001; Kessler et al., 1995; Kessler, 2000). Women also report higher rates of internalizing
symptoms and PTSD following exposure to traumatic experiences with demonstrated rates of
PTSD more than twice the rate of men (e.g., Breslau, Davis, Andreski, & Peterson, 1991; Kessler
et al, 1995; Kessler et al., 2012; Kilpatrick et al., 2013, Norris et al., 1992).
Incarcerated women exhibit higher rates of interpersonal violence and mental health
concerns (e.g., Karlsson & Zielinksi, 2018). Trauma exposure has been deemed a risk factor for
offending and incarceration for women (Gilfus, 2002; Green et al., 2016; Lynch, DeHart,
Belknap, & Green, 2013). Specifically, according to a recent literature review, interpersonal
violence is considered a major contributor towards women’s incarceration through the
development of mental illness and substance use (for a review, see Karlsson & Zielinski, 2018).
Rates of incarcerating women have been increasing and outpacing the rate of incarceration of
men (e.g., Carson, 2015; Minton, 2012; National Resource Center on Justice Involved Women,
2012). Understandably, incarcerated women report particularly high rates of exposure to
traumatic experiences and PTSD, with 56 – 82% of incarcerated women endorsing experiences
of lifetime sexual assault (Karlsson & Zielinski, 2018). Most incarcerated women report
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experiencing multiple types of adversity and interpersonal violence in their lives (e.g., Lynch,
Belknap, & Green, 2013). Incarcerated women also endorse higher rates of PTSD than men
(Komarovskaya, Booker Loper, Warren, & Jackson, 2011), with PTSD 4 to 10 times more
prevalent in incarcerated women than community samples (Green, Miranda, Daroowalla, &
Siddique, 2005; Trestman, Ford, Zhang, & Wiesbrock, 2007; Wolff et al., 2011). Similar to the
comorbidity in community populations, self-reported PTSD has been found to be highly comorbid with symptoms of depression, anxiety, and personality disorders and warrant traumainformed treatment (Harner, Budescu, Gillihan, Riley, & Foa, 2015; Lynch, Fritch, & Heath,
2012). In a sample of women soon to be released from prison who self-referred for treatment
following incarceration, 88% endorsed traumatic event exposure (Wolff et al., 2011). These
findings suggest it is imperative to address trauma within prison systems. A review of the
literature on trauma-informed treatments for incarcerated women (King, 2017) demonstrated
reductions in PTSD symptomology and an additive effect to treatment as usual.
Trauma Treatment
For individuals with PTSD, several of the highly supported evidence-based treatments
include exposure-based components. For example, Prolonged Exposure (PE; Foa, Hembree, &
Rothbaum, 2007), Cognitive Processing Therapy (CPT; Resick & Schnicke, 1992, 1993), and
even adaptations of cognitive behavioral therapy generally require participants to talk, think,
and/or write about trauma-related reminders. In fact, the International Society for Traumatic
Stress Studies (ISTSS; Foa, Keane, Friedman, & Cohen, 2008) and the Veterans
Affairs/Department of Defense (VA/DOD; Bernardy & Friedman, 2012) have identified
exposure therapies as first line treatment recommendations for PTSD.
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Exposure-based techniques are intentionally utilized in treatments for PTSD because,
according to emotional processing theory (Foa & Kozak, 1986), activation of fearful memories
within a safe space can alter the pathological fear network associated with PTSD. By reintroducing memories of trauma cues in a non-dangerous situation, participants learn that fear
experienced in response to these cues is not inherently dangerous (in contrast to the network
created during the time of trauma when these cues were associated with fear). These procedures,
by nature, elicit distress. Therefore, the ability to tolerate distress, at least temporarily, is
necessary to some extent to engage in these trauma-focused treatments.
Theoretically, engaging in these exposure-based treatments demonstrates to individuals
they are capable of experiencing distressing emotions, as they develop a stronger sense of selfcompetence and control over negative affect and stimuli (Rauch, Eftekhari, & Ruzek, 2012), and
therefore may increase their perceived efficacy with tolerating distress. Despite some hesitancy
from therapists to provide exposure-based treatment and/or implement them within incarceration
settings for fear of patient symptom exacerbation or drop out (Becker, Zayfert & Anderson,
2004; Miller & Najavits, 2012; Richard & Gloster, 2007 for review; van Minnen, Hendricks, &
Olff, 2010), there is substantial evidence to support the effectiveness of trauma-related treatment
to improve patients’ symptoms within correctional settings (Karlsson, 2015; Karlsson, Bridges,
Bell, & Petretic, 2014; Karlsson, Zielinski, & Bridges, 2015; King, 2017).
Attrition and Related Concerns
Although exposure-based treatments are considered the gold standard for treating PTSD,
not everyone who begins treatment finishes (See Najavits, 2015 for review). Results from a
meta-analysis found an average attrition, or dropout, rate of 18% from trauma treatments with
wide variability (Imel, Laska, Jakcupcak, & Simpson, 2013). Dropout rate for clinical trials is
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approximately 20% (Bradley, Greene, Russ, Dutra, & Westen, 2005; Hembree et al., 2003)
compared to randomized clinical trials for CPT and PE which average around 28% dropout
(Hembree et al., 2003; Watts et al., 2014). As expected, treatment in real-world conditions have
much higher dropout rates than randomized clinical trials (Schottenbauer, Glass, Arnkoff,
Tendick, & Gray, 2008; Zayfert et al., 2005).
Despite expectations that the distressing nature of exposure would be related to greater
attrition, a literature review found no difference in dropout rates for exposure therapy compared
to other therapies for PTSD (Hembree et al., 2003). This was confirmed and highlighted in the
meta-analysis (Imel et al., 2013): within trauma treatments, drop-out rates vary similarly for
exposure based treatments (0-41%; McDonagh et al., 2005, Neuner et al., 2008) compared to
treatments that do not focus on retelling trauma memories (0 – 48%; Cottraux et al., 2008,
Schaal, Elbert, & Neuner, 2009). Drop-out rates from trauma-specific treatments (involving
explicit retelling of trauma memories) were not significantly different from trauma-neutral (i.e.,
did not require sharing trauma memories) or trauma-avoidant treatments (i.e., did not involve
trauma memories). Dropout rates from trauma-focused PTSD treatments were only higher than
dropout from rates in Present-Centered Therapy (PCT), which was originally intended to be used
as control treatments in several studies but is now considered an active treatment for PTSD (Imel
et al., 2013).
In this study’s particular treatment, research has shown individual differences across
participants regarding treatment completion (i.e., completers and non-completers) and symptom
improvement (Karlsson, 2015; Karlsson et al., 2014; Karlsson et al., 2015). For example,
Karlsson (2015) found demographic differences such that treatment non-completers were
significantly younger, had fewer children, were significantly more depressed (according to total
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sum score and symptom count), and had higher levels of self-blame at baseline than treatment
completers. With regard to symptom improvement, approximately 40% of participants were
above the clinical cut-off for PTSD before treatment but below the cut-off after treatment, while
approximately 45% of participants remained above the clinical cut-off (Karlsson, 2015).
Distress Tolerance and PTSD
The treatment in the current study utilized imaginal exposure, which involves revisiting
trauma reminders and engaging with the emotional content of the memory. Given the potentially
distressing nature of this exercise and recognition of individual differences regarding participant
completion and symptom improvement in previous research of this treatment (e.g., Karlsson et
al., 2015), this study aims to explore these individual differences in treatment completion and
treatment improvement, and gain an understanding of the role of participant’s perception of their
ability to tolerate distress prior to treatment.
Broadly, the term distress tolerance (DT) has been referred to as “the perceived capacity
to withstand negative emotional and/or other aversive states” and/or “the behavioral act of
withstanding distressing internal states elicited by some type of stressor” (Leyro, Zvolensky, &
Bernstein, 2010). Literature has shown different measures (e.g., self-report, behavioral tasks)
may be measuring distinct constructs (e.g., Leyro et al., 2010; Ameral, Palm Reed, Cameron, &
Armstrong, 2014). For the purpose of this study, I utilize the term distress tolerance (DT) to refer
to the distinct conceptualization in the former definition and primarily focus on the self-report
methodological literature measuring perceived capacity to withstand aversive states.
From a biosocial perspective, DT is believed to develop as a result of transactions
between individuals’ biological predispositions and social environments (Crowell et al., 2009;
Linehan, 1993; Zvolensky, Vujanovic, Bernstein, & Leyro, 2010). According to this model,
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some individuals are inherently more likely to experience more intense affect and heightened
emotional reactivity, and therefore may be more likely to fear these emotional responses.
Overall, DT is theoretically related to behavior choices and regulation styles (e.g., avoidance,
numbing, or healthy coping; Vujanovic et al., 2011). Though high distress tolerance is generally
more beneficial than low distress tolerance, moderate levels of DT have been proposed to be the
most ideal as there are myriad concerns related to distress intolerance and overtolerance (Lynch
& Mizon, 2011).
Individuals who rate themselves as having low DT (or high distress intolerance) generally
consider the experience of distress to be unbearable and perceive themselves as unable to handle
being distressed (Simons & Gaher, 2005). Endorsement of low DT indicates an individual feels
relatively consumed by the experience of negative emotions (e.g., Simons & Gaher, 2005;
Zvolensky, Leyro, Bernstein, & Vujanovic, 2011). Given one of the characteristics of low DT is
the desire to alleviate distress, individuals with low DT are more likely to engage in escape or
avoidance behaviors, often impulsively, as an attempt to suppress or mitigate unwanted emotions
(e.g., Anestis, Tull, Bagge, & Gratz, 2012; Simons & Gaher, 2005; Vujanovic, Bonn-Miller,
Potter, Marshall, & Zvolensky, 2011). For example, low DT has been associated with overeating behaviors (Kozak & Faught, 2011), obsessive-compulsive behaviors (Robinson &
Freeston 2014), and cigarette smoking (Perkins, Karelitz, Giedgowd, Conklin, & Sayette, 2010;
Perkins, Giedgowd, Karelitz, Conklin, & Lerman, 2012). Low DT is also common in individuals
diagnosed with borderline personality disorder (Crowell, Beauchaine, Linehan, 2009; Iverson,
Folette, Pistorello, & Fruzzetti, 2012).
Low DT is a risk factor for developing a trauma-related disorder that requires treatment
and is also associated with greater posttraumatic symptom severity (e.g., Duranceau, Fetzner, &
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Carleton, 2013; Fetzner, Peluso, & Asmundson, 2014; Marshall-Berenz, Vujanovic, BonnMiller, Bernstein, & Zvolensky, 2010; Vinci, Mota, Berenz, & Connolly, 2017; Vujanovic et al.,
2011). Findings have differed with regard to associations with particular PTSD symptom
clusters, though several studies have documented an inverse relationship between DT and
symptoms of re-experiencing and avoidance above and beyond variance accounted for by other
related factors (e.g., number of traumas, trait-level neuroticism, participant sex; Fetzner et al.,
2014; Marshall-Berenz et al., 2010; Vujanovic et al., 2011). The nature of relations between
these variables is not fully understood and assumed to be interactional (see Vujanovic et al.,
2015 for review).
Theoretically, the intrusive and unpredictable nature of PTSD symptoms may be
particularly distressing to individuals with low DT (Banducci, Blonigen, Boden, Feldner, &
Bonn-Miller, 2016; Vinci et al., 2017). In a recent study, Hancock and Bryant (2018) found
PTSD exacerbates sensitivity to loss of control, which further impacts the capacity and desire to
approach distressing stimuli. Congruent with the PTSD symptom cluster of avoidance of traumarelated cues, individuals with lower DT would be more likely than those with higher DT to avoid
engaging with triggers (e.g., memories, reminders) that induce emotional or physiological
arousal (Vujanovic et al., 2011). Avoiding these stressful triggers may reinforce the notion that
the individual has limited capacity to tolerate trauma-related affective distress (e.g., MarshallBerenz et al., 2010). Additionally, many behavioral strategies utilized to alleviate distress
(alcohol and substance misuse, non-suicidal self-injury, and binging behaviors) are often
unhelpful and can increase symptomology or lead to a greater negative trajectory (see Leyro et
al., 2010 for review).
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Relatedly, substance use disorders are also relatively common in female inmates (e.g.,
Staton, Leukefeld, & Webster, 2003; Tripodi & Pettus-Davis, 2013) and may be in part because
of the use of substances to cope with traumatic experiences or negative affect intensity (Ullman,
Relyea, Peter-Hagene, & Vasquez, 2013; Veilleux, Skinner, Reese, & Shaver, 2014). Individuals
with PTSD who also have low DT may be at particularly high risk for developing substance use
disorders (Duranceau et al., 2013; Fetzner et al., 2014; Vinci et al., 2017). The distressing nature
of PTSD symptoms, combined with a low sense of efficacy to manage these distressing
emotions, may drive people to seek substances as a way to cope (e.g., Duranceau et al., 2013;
Fetzner et al., 2014). In order to reduce problematic coping, treating the source of distress (that
is, the PTSD), is critical.
Unfortunately, gold-standard treatments that require exposure may be unacceptable to
people with low DT. Individuals with PTSD and low DT may worry about their ability to openly
invite distressing memories and thoughts and may not feel “ready” for exposure-based trauma
treatments (Vujanovic et al., 2015). For individuals enrolled in treatment, experiencing extreme
anger, emotional numbing, and overwhelming anxiety can impede emotional processing, making
it more difficult for individuals to modify the pathological aspects of their trauma memories
during imaginal exposures (Jaycox & Foa, 1996).
Notably, individuals with co-morbid PTSD and SUD who enroll in treatments tend to
have high drop-out rates from treatment (e.g., Brady, Dansky, Back, Foa, & Carroll, 2001;
Coffey et al., 2006), and individuals with lower DT are more likely to drop out from clinical
interventions than those with higher levels of DT. This relationship between low DT and attrition
has been demonstrated in treatments for substance use (e.g., Daughters et al., 2005), depression
(Williams, Thompson, & Andrews, 2013), and mindfulness-based cognitive therapy for patients
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with a history of suicidal depression (Crane & Williams, 2010). Further, PTSD, DT, and gender
may interact. Among men, those with SUD, PTSD, and low DT completed a significantly lower
portion of residential substance use treatment sessions than other men with SUD; for women,
there was no pattern between DT and treatment attendance (e.g., Tull, Gratz, Coffrey, Weiss, &
McDermott, 2013).
Although the concept of DT has been regarded as having trait-like stability, studies have
suggested it may be context-specific (Bernstein, Trafton, Ilgen, & Zvolensky, 2008;
Bornovalova, Gratz, Daughters, Hunt, & Lejuez, 2012; Leyro et al., 2010; Vujanovic et al.,
2011). Further, DT has been shown to be amenable to change through interventions and has been
targeted in psychological treatments because the ability to tolerate temporary emotional
discomfort is considered to be adaptive (Bornovalova et al., 2012; Hayes, Wilson, Gifford,
Folette, & Strosahl, 1996; Linehan, 1993; Metz et al., 2013; Roberts et al., 2017). Therefore,
skill-based group treatments targeting skill deficits (e.g., distress tolerance) have been
recommended as precursors or early intervention strategies for individuals with PTSD
(Vujanovic et al., 2015).
With regard to individual differences in PTSD recovery, greater avoidance coping is an
important predictor of treatment response in individuals with chronic PTSD. Greater pretreatment avoidance predicted greater maintenance of PTSD symptom severity (i.e., less
improvement) across treatment (Badour, Blonigen, Boden, Feldner, & Bonn-Miller, 2012).
Individuals who were relatively highly reliant on avoidant coping strategies and reactive to
trauma reminders were particularly at risk for maintaining or increasing PTSD symptoms in the
first few months following exposure to trauma (Pineles et al., 2011).
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Emotional Stability
A related construct, emotional stability (ES), or neuroticism, is one of the “Big Five”
personality traits (Costa & McCrae, 1992). ES refers to an individual’s general tendency to
experience negative mood states (Costa & McCrae, 1992). Higher ratings of perceived ES have
been shown to be related to lower levels of perceived DT (Kaiser, Milich, Lynam, & Charnigo,
2012; Marshall-Berenz et al., 2010). Theoretically, those who consider themselves to be more
emotional may perceive these more frequent, intense experiences as distressing and therefore
consider themselves as having a lower ability to tolerate emotions than individuals with higher
emotional stability. According to the “hyperemotionality” theory of PTSD, individuals with
PTSD are more likely to experience higher levels of arousal and emotionality (Flack, Litz, Hsieh,
Kaloupek, & Keane, 2000; Litz, 1992; Litz & Keane, 1989; Litz, Litz, & Gray, 2002). Therefore,
ratings of perceived emotional stability may also be important to consider in exploring relations
between DT and treatment persistence, engagement, and internalizing symptom improvement in
this treatment for individuals with histories of sexual abuse.
Current Study
In sum, despite some concerns regarding the distressing nature of exposure, evidence
supports exposure therapy as a gold standard treatment for individuals with PTSD (see Rauch et
al., 2012 for a review). Individuals with low DT perceive themselves as less likely to be able to
cope with negative emotions such as those elicited via treatments for PTSD. Theoretically,
individuals with low DT would be more likely to attempt to avoid experiencing distress, even in
the context of treatment. In treatment-seeking samples, individuals with lower levels of DT may
have the highest need for treatment (i.e., most severe symptoms) but may also be at the greatest
risk for not benefitting from treatment.
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The current study explored how DT relates to treatment persistence (vs. drop out),
engagement (e.g., emotional engagement and detail expressed) during an imaginal exposure to
their traumatic memories, and post-treatment outcomes of DT and internalizing (PTSD,
depression) symptoms in an 8-week exposure-based treatment for incarcerated women who
experienced sexual assault. This project tested four main hypotheses: (H1): Lower baseline
levels of DT would be significantly related to lower persistence in treatment as measured by
(H1a) lower likelihood to complete treatment, and (H1b) greater likelihood of considering
dropping out of treatment; (H2): Lower baseline levels of DT would be significantly related to
less engagement in treatment as evidenced by (H2a) lower levels of emotional engagement and
(H2b) fewer details shared during exposure; (H3): DT would significantly improve from pre- to
post-treatment and (H4): Individuals with lower levels of baseline DT would be more likely to
demonstrate higher levels of post-treatment internalizing symptoms (i.e., PTSD, depression) and
less symptom improvement from pre- to post-treatment, controlling for internalizing symptoms
at baseline. Exploratory qualitative analyses were also conducted to understand motivations for
completers’ treatment persistence.
Method
Participants
Data were collected from women incarcerated in a minimum-security community
correctional facility (the Northwest Arkansas Community Correction Center in Fayetteville,
Arkansas) who enrolled in a voluntary eight-session weekly therapy group focused on recovery
from sexual trauma that happened prior to their incarceration. All women in the facility where
the study was being conducted were incarcerated for non-violent felonies (e.g., selling or using
illegal drugs, financial crimes).
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Data were collected from May 2015 through December 2018 across 17 treatment groups.
In total, 100 women were enrolled in these treatment groups. Eight participants who declined
consent to have their data used for research purposes and seven who did not complete the
primary variable of interest (pre-treatment DT) were excluded. See Figure 1 for flow of
participants. Participants included in analysis were 85 women ages 19 – 53 (m = 31.55; SD =
8.19). See Table 1 for demographics. All participants were functionally literate. Fifteen
participants dropped out of treatment and three participants were missing post-treatment data
yielding 67 participants with post-treatment data.
Procedure
Recruitment. Research participants were those who began voluntary participation in the
exposure-based therapy group, Survivors Healing from Abuse: Recovery through Exposure
(SHARE; Bridges, Karlsson, Zielinksi, & Calvert, 2017). Participants were routinely recruited
via a brief presentation regarding the purpose and content of the group treatment by one of the
group leaders during a daily mandatory meeting at the facility. Women were encouraged to make
a request with a facility coordinator (e.g., counselor, services director) to join the next available
group. Counselors were also encouraged to discuss the group with their clients and encourage
eligible participants to enroll.
Inclusion criteria. All women who signed up for the group were invited to participate in
the treatment. Inclusion criteria were English language fluency and having a prior experience of
sexual violence victimization. As noted above, participants were excluded from data analysis if
they did not consent to their data being used for research purposes or did not complete the
primary measure of interest for this study (Distress Tolerance Scale [DTS]; Simons & Gaher,
2005).
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Data collection and consenting process. This study is part of a larger program of
research. Prior to completing study measures, group leaders provided participants with a written
description of the study purpose, procedures, potential risks and benefits, and rights. Completion
of the study measures was entirely voluntary and conducted via paper and pen prior to the first
session of the treatment group for baseline measures and at the end of the last session for posttreatment measures. Women were not compensated for completing the questionnaires and were
provided a way to discreetly decline to participate if desired by using a two-point consent
process (i.e., consent before and after completion of the measures). Participants must have
provided consent at each time point for their responses to be used for research purposes. All
study procedures were approved by the University of Arkansas’ Institutional Review Board and
the Arkansas State Department of Community Corrections.
Treatment. Each therapy group consisted of eight weekly 1.5-hour sessions. Two to
three clinical psychology graduate students, supervised by a licensed clinical psychologist,
served as group leaders for up to 10 participants at a time. The group format and structure were
informed by Foa and colleagues’ (2007) prolonged exposure therapy (PE) and concentrated on
imaginal exposure, hereby referred to as “exposure” where each participant shared a verbal
trauma narrative. Themes common to victimization (e.g., safety, trust, power and control,
esteem, intimacy) from the works of McCann, Sakheim, and Abrahamson (1988) and Resick and
Schnicke (1993) were also integrated into treatment. Early sessions included discussion of
participants’ confidentiality. psychoeducation about sexual violence and common consequences
of trauma, the role of avoidance in maintaining anxiety, and the rationale for engaging in
imaginal exposure. Discussion of coping (e.g., through breathing and grounding exercises) was
integrated throughout the remainder of the treatment sessions as well.
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The majority of treatment (sessions 3-7) emphasized sharing of trauma memories (i.e.,
imaginal exposure), with one or two individuals who recalled and processed their most salient
trauma memory each session based on the PE protocol (Foa et al., 2007). This treatment was
particularly unique in several ways. There were no between-session assignments in this
treatment. Each participant only shared individually once during the course of the group, for
approximately 25-45 minutes of imaginal exposure (as supported by van Minnen and Foa, 2006),
led by one of the graduate student clinicians. These imaginal exposures consisted of two
components. In the first component, participants were encouraged to recall their most distressing
traumatic experience and “re-live” the experience by describing in detail what happened using
first-person, present-tense language. After the first telling of the story, the second component
involved revisiting the experience again. This time, the leading clinician guided the participant to
process her emotions, thoughts, and physiological sensations related to the trauma by asking
questions that elicit and gently challenge assumptions, reflect on the participant’s earlier
perspectives of the experience, and notice physical reactions. Participants were encouraged to
share supportive comments following each women’s sharing of her story.
Final sessions (sessions 5 – 8) facilitated group conversations integrating the
aforementioned victimization themes and other themes that arose from group sessions, tailored to
the experiences of the individuals in each group. Later sessions also included further discussion
of coping strategies and self-care, psychoeducation about healthy sexual relationships, and
provided resources for future support. For a full description of the treatment protocol, see
Karlsson, Zielinski, and Bridges (2015).
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Measures
Participants completed self-report measures assessing psychological functioning at preand post-treatment (i.e., before the first and at the last treatment sessions). Measures included in
this study are in the Appendix and described below:
Distress tolerance. Distress tolerance (DT) was measured pre- and post-treatment by the
Distress Tolerance Scale (DTS; Simons & Gaher, 2005), a 15-item self-report measure which
examines one’s perceived ability to tolerance emotion distress and includes questions related to
tolerance, appraisal, absorption, and regulation. Participants are directed to think of times they
have felt distressed or upset and rate their agreement with each item (e.g., “Feeling distressed or
upset is unbearable to me”) on a 5-point scale from 1 (Strongly agree) to 5 (Strongly disagree).
Initial exploratory and confirmatory factor analyses by the measure’s authors supported a
four-factor model with four subscales (Simon & Gaher, 2005). For the purpose of this study,
only the single higher-order distress tolerance factor was used. Total scores were calculated as
average scores of responses to all items after reverse-scoring one item (range: 1 to 5). Higher
scores represent higher tolerance for emotional distress.
In the original development studies for the measure, good internal consistency reliability
(α = .82) and test-retest reliability over a 6-month period (intra-class r = .63) were demonstrated
(Simons & Gaher, 2005). As expected, the DTS was negatively associated with measures of
affective distress and dysregulation, and positively associated with mood acceptance and mood
typicality (Simons & Gaher, 2005). Internal consistency reliability for the sample in the current
study was α = .91 for pre-treatment scores (n = 85) and α = .90 for post-treatment (n = 67).
Emotional stability. The Ten-Item Personality Inventory (TIPI; Gosling, Rentfrow, &
Swann, 2003) was used as a brief personality trait measure. Each of the ten items (e.g., “I see

16

myself as calm, emotionally stable”) were rated on a 7-point scale ranging from 1 (disagree
strongly) to 7 (agree strongly). For this study, only the Emotional Stability (ES) subscale, which
is comprised of two items, was used as a control variable. Cronbach alpha for this scale was .73
in the original measure development sample (Gosling et al., 2003). In measure development, the
TIPI demonstrated significant convergent correlations with other personality measures; for
example, the ES scale was correlated at r = .81 with the ES scale of the Big-Five Inventory (BFI;
John & Srivastava, 1999). Gosling and colleagues (2003) demonstrated the TIPI had slightly
lower correlations than the BFI but was still determined to be a strong indicator of external
correlates. The TIPI also demonstrated test-retest reliability over six weeks (r = .72 for the entire
measure). In the current sample, the two items on the ES subscale were significantly correlated (r
= .345, p = .001) with a Cronbach alpha of .51, (n = 84) for the ES subscale score at pretreatment and remained significantly correlated (r = .485, p < .001) with a Cronbach alpha of .63
(n = 67) at post-treatment.
Treatment persistence. Treatment persistence was measured by records of treatment
attendance and completion, and retrospective recall of drop-out intentions. Each is described
below. In addition, qualitative data regarding drop-out intentions and motivations for treatment
persistence gathered at the end of treatment were analyzed for themes.
Treatment completion. Participants must have shared their own trauma narrative through
imaginal exposure and attended at least six of the eight sessions in order to be considered a
“treatment completer.” Individuals were able to voluntarily leave the treatment group without
consequence. Attendance and imaginal exposure records were maintained by graduate student
clinicians.

17

Drop-out intentions. In the post-treatment measures, treatment completers reported on
their desires to end treatment early. The measures included a question asking if the participant
considered dropping out of the group (yes/no). If yes, the participant also indicated via
checkmarks at which time points (e.g., before the first session, before sharing their personal
trauma narrative) they considered dropping out. Desire to drop out (i.e., not persist) was coded as
a sum of number of time-points (0 – 7) the participant considered dropping out. This form
regarding drop out considerations was implemented in March 2016 and therefore not available to
participants in the first three groups (n = 21) included in this project.
Qualitative data. Two open-ended questions were included in the written assessment
packet with regards to personal motivations for persistence: “Why did you consider dropping
out?” and “What made you stay in this group?” These data were collected from treatment
completers at post-treatment. The readability of these open-ended questions was below a 5th
grade reading level.
Engagement. Treatment engagement was measured using two categories of variables:
emotional engagement and degree of detailed descriptions of trauma narrations.
Emotional engagement. Emotional engagement was measured in two different ways
during the duration of this study. For the first eight groups (n = 37) therapists were asked to rate
each participant’s “level of expressed emotion” during their imaginal exposure, using a 5-point
scale (i.e., 1 = none, 2 = low, 3 = medium, 4 = high, 5 = extreme). For the latter ten groups (n =
46), therapists were asked to rate each participant’s “average” level of expressed emotion and
“highest” level of expressed emotion during their imaginal exposure, using a 5-point scale (i.e., 1
= none, 2 = low, 3 = medium, 4 = high, 5 = extreme).
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Scores for each participant were first averaged across raters. Higher scores indicated
greater emotional engagement during exposure sessions. In order to include as many participants
as possible, I created a single composite score for each participant. For participants from the first
eight groups, average scores across raters from the “level of expressed emotion” variable were
used. For participants from the latter 10 groups, the mean of raters’ scores on the two newer
items (“average” and “highest” level of expressed emotion) were significantly different from the
“level of expressed emotion” from the first eight groups. However, these two newer items
(“average” and “highest”) were correlated with each other at r = .610, (p = <.001) and averaged
to create a single mean score. This mean score derived from the combination of the two newer
items from the latter groups was not statistically different from the “level of expressed emotion”
from the first groups [t (43.77) = -0.51, p = .613]. Therefore, this combination (of “average” and
“highest” ratings) was used as a composite score for participants in the latter ten groups. Ratings
between the three clinicians were highly consistent (r = .66 - .83, p < .001).
Trauma narration details. Clinicians also rated the degree of personal details shared by
the participant during their trauma narration. Details were rated on a 5-point scale (i.e., 1 = none,
2 = low, 3 = medium, 4 = high, 5 = extreme). Scores from group leaders were averaged to yield a
single rating for each participant, with higher scores indicating greater personal details shared
during the exposure. Examination of inter-rater reliability for level of detail amongst all three
clinicians revealed low non-significant correlations between Rater 3 and the other two raters (r =
-.12, p = .692; r = -.19, p = .57), whereas Raters 1 and 2 were highly correlated (r = .69, p <
.001). Therefore, ratings of level of detail shared during exposure used an average of ratings by
Raters 1 and 2.

19

Internalizing symptoms. Two measures of internalizing symptoms (one each for
posttraumatic stress and depression) were assessed pre- and post-treatment. Each is described
below.
PTSD. Posttraumatic stress symptoms were assessed using the Posttraumatic Checklist
for DSM-5 (PCL-5; Weathers et al., 2013). The PCL-5 is a 20-item self-report questionnaire that
assesses symptoms of PTSD. Participants rated the extent to which they have been bothered by
each problem (e.g., “repeated, disturbing, and unwanted memories of the stressful experience”)
on a scale from 0 (not at all) to 4 (extremely). The PCL-5 yields total symptom severity scores
(range 0-80) with a preliminary cut-point suggestion for clinical symptomology of 33.
The PCL-5 was adapted from previous versions of the checklist. Bovin and colleagues
(2015) validated the current version of the PCL-5 against the Clinician Administered PTSD
Scale for DSM-5 (CAPS-5; Weathers, et al., 2013, the gold standard for diagnostic interviews).
The PCL-5 has been one of the most widely used self-report measures of PTSD (Blevins,
Weathers, Davis, Witte, & Domino, 2015). In studies examining psychometric properties of the
PCL-5 with trauma-exposed college students, there was strong internal consistency (α = .94) and
test-retest reliability over one-week (r = .82), as well as convergent validity compared to other
measures of PTSD (rs = .74 - .85) and discriminant validity compared to depression, antisocial
personality features, and mania (rs = .31 – 60; Blevins et al., 2015). Confirmatory factor analysis
indicated adequate fit with the DSM-5 four-factor model (Blevins et al., 2015). Reliability in this
sample was α = .94 (n = 84) for pre-treatment scores and α = .93 (n = 63) for post-treatment
scores.
Depression. The nine-item Patient Health Questionnaire (PHQ-9; Kroenke, Spitzer, &
Williams, 2001) was used to assess symptoms of depression experienced during the two weeks
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prior to measure administration. Items represent symptom criteria of depressive disorders (e.g.,
“little interest or pleasure in doing things”). Answer choices range from 0 (not at all) to 3 (nearly
every day). Items are summed to create a total score (range 0 – 27) in which higher scores
indicate greater levels of depression. Scores of 5, 10, 15, and 20 represent cut-points for mild,
moderate, moderately severe, and severe depression, respectively (Spitzer et al., 1994).
Internal reliability of the PHQ-9 is considered excellent (α = .89) in the PHQ Primary
Care Study with excellent test-retest reliability (r = .84) across 48 hours (Kroenke et al., 2001).
Criterion validity was demonstrated in a sample of 580 primary care patients who underwent an
independent diagnostic interview by a mental health professional. Construct validity was
established by strong associations between PHQ-9 scores and measures of functional status,
disability days, and symptom-related difficulty (Kroenke et al., 2001). Reliability in the current
sample was α = .87 (n = 81) for pre-treatment scores and α = .82 (n = 65) for post-treatment
scores. Overall, all measures were at or below a 9th grade reading level.
Analytic Approach
Hypothesis 1, examining the relation between DT and persistence, was tested in a few
ways. First, logistic regression was utilized, regressing completion status (yes/no) on pretreatment DTS scores, to determine if baseline DT predicted treatment completion status (H1a).
Second, logistic regression was utilized again, regressing desire to drop out (yes/no) on pretreatment DTS scores, to determine if baseline DT predicts the desire to drop out (H1b).
For those who indicated yes on the aforementioned item, I computed a correlation
between the number of time-points participants considered dropping out and baseline DTS
scores, and estimated a Poisson regression model, to test if baseline DT was related to the
duration of time participants considered dropping out of treatment (H1c).
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Qualitative responses regarding desire to drop out of group and motivations to remain
were analyzed using the Sift & Sort, Think & Shift qualitative data analysis approach (Maietta,
2007). This iterative process combines tenets and practices from phenomenology, grounded
theory, case study, and narrative research (Maietta, Hamilton, Swartout, & Petruzzelli, 2018).
The approach emphasizes subjective reports and discourages reporting quantitative statistics on
qualitative data. This process involves “diving in” and “stepping back” to engage in analytic
shifts to allow data content to define analytic decision-making and directions (see ResearchTalk,
2017 for more information). Although there was no formal hypothesis between participants of
varying levels of DT, participants with DTS scores below 3 were considered to have low DT and
participants with DTS scores equal to or greater than 3 were considered to have moderate to high
levels of DT, in order to explore potential differences. This split was determined by examining
bivariate scatterplots between baseline DT and outcome variables.
Engagement-related hypotheses (H2) were explored via regression analyses. Bivariate
scatterplots were examined to determine the appropriate terms (e.g., potential transformations) to
include in the regression. LOESS (locally estimated scatterplot smoothing) lines fitting 99% of
data points were added to bivariate scatterplots to observe potential non-linear patterns in
variable relations. Engagement-related variables were entered in two separate equations with
across-rater averages of level of emotional engagement (H2a) and level of detail shared (H2b)
each regressed on pre-treatment DTS scores.
It is important to note that post-treatment data were unavailable for individuals who did
not complete treatment, as assessments were administered at the last session of group treatment.
Therefore, analyses including post-treatment and change variables only included data from
participants who completed treatment.
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A cross-lagged structural equation model was proposed to test hypotheses 3 and 4 to
examine the relations between pre- and post-treatment DTS scores and symptom outcome (i.e.,
PTSD, depression; see Figure 2). The model in Figure 2 assumed PTSD and depression would
converge as a unitary factor of internalizing; if PTSD and depression did not load onto a single
factor of internalizing in subsequent analyses, the plan was to analyze separately. However,
bivariate graphs of baseline DT and several outcome variables (DT, PTSD, depression) posttreatment and change scores demonstrated non-linear relationships (see Figures 3 - 8). Adding a
quadratic variable to the proposed model would be too complex and yield an unstable model
given the relatively small sample size and increased number of predictors. Therefore, when
appropriate, regression equations were modeled to included pre-treatment DTS scores in both
linear and quadratic terms. Pre-treatment DT was added independently in step 1 and step 2
included both the linear and quadratic pre-treatment DT scores to statistically examine model
fits.
In order to examine the robustness of findings, hierarchical regression analyses were
repeated to control for and determine the unique influence of the general trait-like attributes of
emotionality. Mean ES subscale score from the TIPI added independently in Step 1. Further,
primary analyses exploring relations between pre-treatment DT and outcome change scores were
repeated using a last observation carried forward (LOCF) procedure (Xu, 2009) to include all
participants (completers and non-completers). LOCF was used to assume no change in symptom
scores (change scores = 0) for treatment non-completers given data suggesting the relative
stability of DT and chronicity of PTSD and depression, especially across a 2-month period (e.g.,
Javidi & Yadollahie, 2012). Bivariate scatterplots of baseline DT and outcome variables using
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LOCF were examined to determine whether or not quadratic terms would be included in
regression analyses.
A priori power analyses were completed using G*Power 3.1.9.2 (Faul, Erdfelder,
Buchner & Lang, 2009; Faul, Erdfelder, Lang, & Buchner, 2007). For two-tailed correlations
with a bivariate normal model, α = .05, power of 0.8, a desired moderate correlation of 0.3 with
the null hypothesis correlation of 0, the recommended sample size was 84. Using the same
parameters for two-tailed t-tests using point biserial models, the recommended sample size is 82.
For linear multiple regressions with a fixed model to determine R2 deviation from 0, using 4
predictors and the minimal effect size of interest (0.15), a sample size of 85 was recommended.
The sample size of 85 enrolled participants meets this minimum recommendation; however, the
number of treatment completers with usable data (n = 67) was below this threshold for adequate
power.

24

Results
Descriptive Statistics
Approximately 82% of participants (n = 70) completed treatment. There were no
significant differences (all p values > .05) in demographics for participants who completed
treatment compared to those who dropped out. Relatedly, pre-treatment scores did not
significantly differ for participants who completed treatment compared to those who did not
(Table 2).
On average, participants self-reported moderate levels of DT at baseline (M = 2.72) with
wide variability in scores (SD = 0.89; Figure 9). Pre-treatment DT scores were not significantly
related to any demographic variables. Pre-treatment PTSD scores (M = 39.96; SD = 19.77) were
also relatively moderate to high. Approximately 66% of the sample (n = 56) met criteria for a
provisional diagnosis of PTSD at baseline according to the PCL-5 cutoff score. Pre-treatment
depression scores (M = 13.02; SD = 6.51); the mean score fell in the range of “moderate”
depressive symptoms. Approximately 42% of participants (n = 36) scored in the range of
“moderately severe” or “severe” depressive symptoms according to PHQ-9 scoring guidelines
(i.e., scores equal or greater than 15). All pre-treatment scores were significantly correlated (p <
.001) with each other; post-treatment scores were also significantly correlated (p < .01) with each
other (see correlation matrix in Table 3).
After treatment, overall scores of distress tolerance on the DTS significantly increased
(see Table 4 for comparison of all pre- and post-treatment variables). Average pre-treatment
scores were below the median score of 3, but post-treatment scores were above the median. PCL5 scores decreased significantly from pre- to post-treatment. These improvements also reflected
clinical improvement as less than 12% of participants (n = 10) remained above the clinical cutoff
for PTSD after treatment. Depression scores on the PHQ-9 decreased significantly pre- to post25

treatment. This symptom reduction was also clinically significant; less than 6% of participants
who completed treatment (n = 5) indicated scores at or above the moderately severe range after
treatment.
Participants endorsed relatively moderate emotional stability (ES) scores, below the
median of the range (sum = 4) at pre-treatment and above the median at post-treatment. Contrary
to expectations of relative stability, the average decrease on the TIPI ES subscale reflected a
statistically significant change in scores from pre- to post-treatment.
Hypothesis 1: DT and Treatment Persistence
Contrary to H1a, baseline DT was not predictive of treatment completion [χ2 (1) = 0.35, p
= .552, DT OR = 1.21, 95% CI: 0.64 – 2.31]. See Figure 10 for illustration of DT variability for
both groups (i.e., treatment completers vs. non-completers). Mean baseline DT scores for those
who completed treatment were not significantly different from those who dropped out of
treatment (Table 2).
Hypothesis 1b was also not supported. Of the 41 participants who provided posttreatment responses to this question, over 60% considered dropping out of treatment. Baseline
DT was not statistically predictive of whether or not participants who completed treatment had
considered dropping out of treatment, χ2 (1) = 0.82, p = .365, DT OR = 1.36, 95% CI: 0.69 –
2.68. Similarly, baseline DT scores were not significantly different between those who had
considered dropping out (m = 2.75, SD = 0.80, n = 25) and those who did not (m = 2.54, SD =
0.91, n = 24), t (47) = -0.89, p = .377.
Further exploration of the time periods that treatment completers considered dropping out
were explored via H1c. Twenty of the 25 participants who endorsed considering dropping out
selected which time-points they considered dropping out. On average, these participants
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considered dropping out at two time-points (m = 2.05, SD = 1.54) of the six discrete time-point
choices offered. Baseline DT was not significantly correlated with the number of time periods
participants considered dropping out (r = -.31; p = .179). The results did not change and
remained non-significant when explored as a Poisson regression (Baseline DTS was correlated
with number of time points the person considered dropping out at B = -.164 [SE = 0.30], 95%
confidence interval for B: -.76, .43, p = .588).
Qualitative findings. Most (n = 24) of the 25 participants who considered dropping out
wrote a comment. Individuals’ qualitative responses to open-ended questions were relatively
short; most often, responses were one sentence or a sentence fragment.
Fear was the most commonly endorsed theme for why participants considered dropping
out. This included fear of sharing their story with others (which also highlighted trust, judgment,
and confidentiality issues), fear of re-living the experience, and fear of the emotions imaginal
exposure would elicit. For example, a representative comment was “[I w]as just scared and [it]
was very hard for me because I had to relive it again.” Participants with moderate to high levels
of DT also noted fear of emotions, with one participating noting, “It was getting too emotional
for me to handle.”
Participants who considered dropping out of treatment provided reasons why they
persisted and completed the group. Prevalent themes included the desire to recover, heal, or
reduce symptoms; keeping their commitment; encouragement from others; and selfdetermination.
Hypothesis 2: Treatment Engagement
Hypothesis 2a: DT and emotional engagement. An examination of a bivariate
scatterplot for baseline DT and emotional engagement revealed a non-linear relationship, as the
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slope appears to flatten before the midpoint (Figure 11); therefore, the regression included both
linear and quadratic terms (i.e., the predictor variable squared), as the lower order variable is also
required in higher order equations). Baseline DT significantly predicted emotional engagement
(see Table 5 for details). Although not represented in a linear trend, participants with lower
levels of DT were rated higher on emotional engagement during their exposure, as compared to
participants with moderate to high levels of DT.
Hypothesis 2b: DT and detail shared. The bivariate scatterplot of baseline DT and level
of detail shared during exposure appeared relatively linear (Figure 12); therefore, a quadratic
term was not included in this model. Baseline DT was a significant predictor of level of detail
shared during the participant’s exposure session (see Table 5). Lower DT predicted higher levels
of detail shared.
Treatment Outcomes and Symptom Improvement
Baseline DT was significantly related (p < .001) to all outcome change variables (DT,
PTSD, and depression; see Table 3). Regression equations were modeled to included pretreatment DTS scores in both linear and quadratic terms with pre-treatment DT in step 1 and both
the linear and quadratic pre-treatment DT scores in step 2.
Hypothesis 3: Distress tolerance improvement. Two hierarchical linear regressions
examined how pre-treatment DT and its quadratic term predicted post-treatment DT and DT
change scores. Pre-treatment DT significantly predicted both post-treatment DT and DT change
scores (see Table 6). The model including the quadratic term of pre-treatment DT accounted for
more total variance than the linear model. With regard to partial correlations, the linear terms
remained significant and the quadratic terms were marginally significant. Overall, lower levels of
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pre-treatment DT were significantly associated lower post-treatment DT scores but higher levels
of change in DT from pre- to post-treatment.
Hypothesis 4: DT and internalizing symptoms. For PTSD and depression equations,
pre-treatment scores for the outcome variable were controlled for in Step 1, the linear pretreatment DT term was included in Step 2, and Step 3 added the quadratic pre-treatment DT term
to examine predictions of symptom change or post-treatment scores as the dependent variables.
PTSD. Pre-treatment DT significantly predicted post-treatment scores and change in
PTSD symptoms, controlling for pre-treatment PTSD symptoms (see Table 7). Pre-treatment DT
was independently significant in both models; pre-treatment PTSD was only a significant
predictor in models of PTSD change, but not post-treatment scores.
Depression. Pre-treatment DT significantly predicted post-treatment scores and change in
depression symptoms, controlling for pre-treatment depression symptoms (see Table 8). Pretreatment DT was independently significant in both models; pre-treatment depression was only a
significant predictor in models of depression change, but not post-treatment scores.
Robustness Checks
Emotional stability. To explore the impact of neuroticism, or emotional stability (ES) on
symptom change, the ES subscale from the TIPI was entered into the first step of each of the
models. When ES was entered into the models, they all remained significant. ES was not a
significant predictor of any model, even when entered alone in step 1; however, with regard to
partial correlations, predictor terms for DT (linear and quadratic) remained significant predictors
at similar levels of significance or marginal significance, unaffected by the addition of ES into
the model (see Tables 9-12). Overall, the inclusion of ES in these models does not account for
change.
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LOCF. LOCF procedures explored the robustness of findings by including all
participants, as opposed to only treatment completers. Bivariate graphs of pre-treatment DT and
DT change scores using LOCF appeared to be linear (see Figure 13). A variable of DT change
scores using LOCF was regressed on pre-treatment DT scores. This model was significant (p <
.001) and pre-treatment DT significantly predicted DT change including all participants using
LOCF (see Table 10).
Bivariate graphs of pre-treatment DT and outcome variable change using LOCF did not
appear to be linear (see Figures 14 and 15). Similar to the regression models run between
baseline DT and outcome variables, a hierarchical regression was run with the LOCF change
variable as the outcome, pre-treatment symptom scores were entered in Step 1, linear term for
DT added in Step 2, and quadratic term added in Step 3.
With regard to PTSD, the regression models including pre-treatment DT variables and
PTSD as predictors remained significant (p < .001; see Table 11). However, change in PTSD
score using LOCF was only significantly predicted by pre-treatment PTSD scores; neither
variable of pre-treatment DT was significantly predictive. Similar relations were shown when
predicting change in depression scores from pre- to post-treatment. The model including pretreatment DT variables and depression as predictors was significant (p < .001; see Table 12).
Pre-treatment depression predicted change in depression scores using LOCF; however, neither
pre-treatment DT variable was a significant predictor.
Discussion
Incarcerated women have extremely high rates of sexual violence and post-traumatic
stress, especially compared to the general population. These individuals would likely benefit
from trauma treatments. Gold standard trauma treatments utilize imaginal exposure, though some
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professionals and clients worry may be too distressing for individuals with low levels of DT.
This study explored relations between DT and individual differences in treatment persistence,
engagement during exposures, and symptom improvement in response to an exposure-based
group treatment for incarcerated women who experienced sexual assault. I predicted individuals
with lower DT would be less likely to complete treatment, less engaged during exposures, and
demonstrate less improvement in internalizing symptoms of PTSD and depression.
Consistent with previous literature of incarcerated women highly affected by trauma
exposure (Karlsson & Zielinski, 2018), participants in this study demonstrated high rates of
untreated psychiatric symptomology. For instance, 66% of the sample endorsed clinical pretreatment symptoms of PTSD and 42% endorsed clinical symptoms of depression.
Approximately half of the sample indicated pre-treatment DT scores below the mid-point;
participants demonstrated a wide range of variability in baseline levels of DT. PTSD symptoms
in this sample were still significantly related to low pre-treatment DT, consistent with prior
literature (e.g., Fetzner et al., 2014). Participants also demonstrated high variability in ES scores
at pre-treatment with the average scores below the mid-point.
Treatment Persistence versus Drop Out
Seventy of the 85 participants with pre-treatment data completed treatment, which
constitutes a 17.6% attrition rate. This is on par for the overall average rate of attrition from
trauma treatments (about 20%), but is relatively lower than attrition rates for individual trauma
treatments in community samples or those offered in group format (up to 40%; Imel et al., 2013).
One plausible reason for this difference is the short-term nature of this 8-week study. For
example, in a study examining exposure utilization and completion in a clinical setting,
participants completed an average of 16 sessions prior to dropout (Zayfert et al., 2005).
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Although actual drop-out was low, more than 60% of participants who completed
treatment endorsed having considered dropping out of treatment at some point. This rate seems
consistent with general attitudes about exposure-related therapy in the literature (e.g., Becker et
al., 2004; Richard & Gloster, 2007; van Minnen et al., 2010). The fact that more than half of
treatment completers had considered dropping out but ultimately did not do so suggests concerns
were likely assuaged by participating in therapy. As suggested by qualitative comments,
participants may have been influenced to remain in group by increased trust built within the
group, increased confidence in themselves and their own abilities, persistence, or the passing of
time (i.e., not worth dropping out after the majority of sessions completed).
Indeed, all participants who completed an exposure completed the group treatment (that
is, no one completed an exposure and then dropped out of group). This statistic is consistent with
prior literature that initiating exposure therapy is associated with greater likelihood of completing
treatment (Zayfert et al., 2005). Given that many participants who cited a reason for considering
dropping out indicated fear related to the exposure process, this finding is not surprising. Once
participants completed the exposure, the most emotionally distressing component of treatment
was finished.
Themes highlighted in qualitative findings regarding considerations of dropping out of
treatment were similar to cognitive sequelae of traumatic experiences. For example, patterns of
fear and issues related to trust are common post-traumatic responses (e.g., APA, 2013; McCann
et al., 1998; Resick & Schnicke, 1993) and appeared often in participants’ qualitative responses
to questions. As expected, some of the concerns expressed were fears directly related to the
imaginal exposure component of the treatment and often were realistic fears, including the
potential for their confidentiality to be broken within their living environment by other group
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members or fears of experiencing increased symptoms after exposure (e.g., nightmares,
increased anxiety and hypervigilance). Other fears related to the imaginal exposure were also
logical but less likely to be realistic, including being negatively judged by other group members,
fear of their emotions escalating without relief, and worries about substance use relapse (within
the prison-setting where they did not have access to substances). Many reasons appeared to relate
directly to the concept of DT, including a participant who described the treatment as “too
emotional for me to handle.” Participants’ rationales for remaining in the treatment group
included a desire to commit for their own benefit and/or other group participants. The majority of
comments mentioned something related to helping, healing, or recovery. This further supports
this notion that participants’ level of commitment was relatively high at baseline, even if they
contemplated dropping out.
It is important to note the prison setting itself may be related to the relatively low
treatment attrition rate observed in this study. First, offering treatment within prison may have
increased participation due to fewer competing responsibilities or activities available to them. In
contrast to traditional outpatient settings, there were fewer logistic barriers to receiving treatment
(e.g., transportation, child care) that often interfere with community participation in treatment
groups. Second, participants were adequately informed of the nature of the group and its
requirements (e.g., sharing a story of their traumatic experience) and had the opportunity to
speak with their counselors prior to enrolling in group. This fully informed consent prior to the
beginning of group, coupled with the fact that participants voluntarily chose to enroll in this
treatment group prior to completing baseline measures, may indicate that this sample had a
higher level of commitment than a general sample enrolling in a community treatment group.
Third, participants were usually acquainted with the other group participants due to co-living

33

arrangements within the facility. This may have contributed to a sense of familiarity, collegiality,
and potentially comfort with the other group members and therefore may have further
contributed to the participants’ sense of commitment to the group. These notions of participant
commitment to peers and their own recovery are supported by some of the qualitative comments
provided by participants who considered dropping out of the group but ultimately completed
treatment. On the other hand, as noted in qualitative comments, it is also possible that living onsite with other group members may have dis-incentivized some participants to enroll in group or
contributed to dropout, especially if there was a prior history of interpersonal conflict or low
levels of trust between potential group members.
Hypothesis 1: DT and Treatment Persistence
Contrary to my hypothesis, baseline DT did not predict treatment persistence (i.e.,
completion versus drop out). On the whole, this indicates individuals with lower DT did not
systematically, intentionally leave the group to avoid the exposure exercise. Baseline DT also did
not predict consideration of drop out in treatment completers. For those who considered dropping
out, baseline DT also did not predict the number of time periods participants held these concerns.
Qualitative comments about reasons for considering dropping out or motivations to stay in the
group also did not differ by DT.
Non-significant relations between DT and treatment persistence contrast previous
literature which demonstrates high rates of treatment attrition from individuals with low levels of
DT (e.g., Daughters et al., 2005). Based on the construct of DT (Simons & Gaher, 2005)
comments regarding fear of increased symptoms and inability to manage difficult emotions were
not expected from participants with higher levels of DT, but were reported in qualitative
comments.
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Several explanations are offered for why this hypothesis was not supported. First, this
study involved a voluntary commitment following descriptions of the treatment protocol.
Therefore, although there was no comparison to methods of treatment in other studies,
individuals with lower levels of DT may have been more aware than usual of treatment
expectations in this study. As supported by qualitative comments, once participants decided to
sign up for treatment, they were less likely to leave after forming relationships with other
participants in the treatment group. It is possible that many eligible participants (women affected
by histories of sexual assault experiences) with very low DT declined enrollment and
participation in this exposure-based treatment and therefore did not complete pre-treatment
measures.
Secondly, since DT has been shown to be context-specific (see Leyro et al., 2010), it is
possible the general measure of DT was not a good predictor of treatment-specific state-level DT
(the self-perceived ability to tolerate telling a personal trauma narrative via exposure). Baseline
DT ratings were intended to be general, and not specifically related to completion of treatment or
the endurance of a trauma-related exposure activity. However, participants’ perceptions of their
ability to complete the exposure and treatment was not assessed, and may have varied from an
overall level of general DT. By enrolling in treatment, these participants indicated a desire and
some level of belief in their capabilities to engage in treatment. It is also possible their
willingness to sign up was influenced by the knowledge they would have the support of
clinicians and other group members and therefore DT in the context of treatment may be higher
than general perceptions.
Third, levels of self-reported DT varied widely in completers and non-completers, with
both groups having participants spanning the range from low to high levels of baseline DT

35

(Figure 10). This non-significant finding between baseline DT and treatment persistence suggests
motivations for dropping out of treatment may not be related to level of DT. This is further
supported by the similarity of comments amongst treatment completers with a range of baseline
DT. A comment from an individual with relatively low baseline DT, “I am strong and a
survivor,” indicated a greater hope and capacity in their own self-efficacy than would have been
predicted by baseline DT score. Participants with low baseline DT also cited the utility of the
imaginal exposure, “I need it to help me tell me story,” and “because I felt like it would help me
feel better by getting it off my chest.” These comments indicated a recognition throughout the
group of the rationale for exposure, which they may or may not have been aware of or interested
in prior to the first few sessions of treatment.
Fourth, prior work (Tull et al., 2013) suggested relations between DT and attrition in
substance use recovery may be moderated by gender and only present for men, who generally
exhibit more externalizing symptoms of PSTD than women. Perhaps the relation between
baseline DT and treatment persistence is more complex and affected by gender, trauma
victimization, substance use, or incarceration.
Given the finding that baseline DT did not predict treatment dropout, I would have
further expected it to predict consideration of dropout. In other words, I would have expected the
reason for lack of significant findings between baseline DT and dropout to be that participants
with lower levels of DT may have remained in treatment but at least considered dropping out
prematurely. However, since the majority (60%) of completers considered dropping out, it makes
sense these participants spanned a variety of baseline DT scores.
This study attempted to identify participants who might be more likely to drop out based
on baseline DT scores and related fears of exposure in order to identify and potentially target
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these individuals (e.g., pre-treatment sessions to bolster DT) to increase their likelihood of
treatment completion. However, baseline DT was not significantly associated with treatment
persistence, considerations of dropping out, nor differences in qualitative comments. Therefore,
these findings do not implicate implementation of DT-skills booster sessions prior to beginning
treatment as suggested in the literature (Vujanovic et al., 2015). Instead, these results suggest
participants with low baseline DT are just as capable of completing treatment as those with
moderate to high levels of DT (at least if they are provided with information about treatment up
front and enroll voluntarily).
Treatment Engagement
Emotional engagement. Therapist ratings for emotional engagement shared were mostly
centered around average with wide variability across participants. This suggests some
participants were highly emotionally engaged with their exposure while others were not. Scores
on emotional engagement during exposure were between the values of 2-5 (full possible range of
values 1-5). This indicates that no participant was rated as expressing the lowest possible level of
emotion, on average. Although this is likely an accurately representation of the experiences and
due to the nature of the imaginal exposure activity, it is possible the lack of low ratings could be
due to a bias on the part of all clinicians. If these reduced scores were a result of bias, it would
mean these results and the strength of any findings could be over-inflated. However, they are
more likely to have been influenced by the clinician who led the exposure appropriately eliciting
emotions from under-engaged participants during exposure.
The therapist guidance during the exposure-based activity might contribute to the
generally higher levels of emotional engagement. Therapists specifically coached participants
during their exposure to elicit emotions and details related to their traumatic experience. It is
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likely they provided more guidance for participants who may have naturally presented as
emotionally under-engaged. Relatedly, therapists occasionally encouraged participants to share
during sessions when they were already evincing emotional reactivity or expression of
overwhelming emotion (that may otherwise be “shut down” or suppressed between sessions).
Overall, it appeared participants who completed an exposure were active participants in the
exercise, demonstrating emotional responses.
Hypothesis 2a: DT and emotional engagement. For participants who completed an
exposure, baseline DT was significantly related to emotional engagement during the exposure,
but in the opposite direction than predicted. It was hypothesized that individuals who rated
themselves as having lower ability to tolerate distress would be less likely to engage emotionally.
However, lower baseline DT was related to higher level of emotional engagement during
exposure.
The relationship between baseline DT and emotional engagement was non-linear,
demonstrating a negative slope for participants with relatively low baseline DT. Emotional
engagement ratings began to level off towards a horizontal trending line as baseline DT scores
neared the midpoint of 3 (on a scale from 1-5). Emotional engagement ratings were higher (score
of approximately 4) for participants with low baseline DT than for participants with moderate to
high ratings of perceived baseline DT (emotional engagement scores slightly above 3). This
trend suggests individuals with the lowest perceived DT at baseline were the most likely to be
emotionally engaged in their own exposures.
Literature suggested individuals with low DT, who have low confidence in their
perceived ability to tolerate distress, would actively avoid and attempt to suppress distressing
emotional experiences (e.g., Vujanovic et al., 2011). The finding that individuals with lower
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levels of DT were most likely to be emotionally engaged in their exposures contradicts this
prediction, at least in the context of the exposure. Similarly, in accordance with the theory of
distress overtolerance (Lynch & Mizon, 2011), I would have expected individuals with the
highest baseline ratings of DT to be the most emotionally engaged in their exposures. Instead, it
seemed as though participants with low baseline ratings of DT appeared the most emotionally
affected by these distressing experiences.
In fact, high levels of emotional engagement may be reflective of emotional
dysregulation or less control of emotions, both of which are characteristic of individuals with
low DT (e.g., Zvolensky et al., 2010). Displaying higher average levels of emotion could also
represent emotional flooding and the sensation of being overwhelmed by distressing emotions.
Participants with lower levels of DT may have perceived the exposure as an emotionally
overwhelming experience, which they might typically attempt to avoid. However, they were not
able to circumvent emotional engagement due to the nature of the clinician-guided exposure. The
display of intense emotions may be part of what these participants with lower levels of DT were
concerned about experiencing and generally attempt to avoid.
This externally-rated variable of emotional engagement is intended to be an objective
rating of level of emotion expressed during exposure. This variable does not attempt to describe
how well the participant appears to be tolerating the emotions elicited during their exposure or
regulating their emotional responses. Similarly, this variable does not give us information about
the participants’ perceptions of the experience (e.g., how uncomfortable or distressed they felt
internally or physiologically). This means, regardless of the rated level of emotional engagement,
the participant could have been highly uncomfortable during the experience (congruent with low
DT) or felt confident in their ability to experience those emotions. It was unanticipated that
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individuals who rated themselves as uncomfortable with highly emotional experiences were the
ones who demonstrated the most emotionality, regardless how they felt during the experience.
The ratings of emotional engagement addressed the level of emotion expressed without
acknowledging, distinguishing, or labeling the emotion(s) expressed. It is not known whether the
emotions expressed reflected sadness, anger, fear, or grief. Relatedly, expressing higher levels of
emotion does not necessarily reflect processing of emotion or the level of utility (e.g., how
constructive it is to express said emotion) of emotional expression. Jaycox and Foa (1996)
described how some emotional responses (e.g., anger, overwhelming anxiety) can interfere with
fear activation during exposures (and impede recovery). Anger, for instance, emerges in the
context of injustice, and is included in the defining symptoms of PTSD. In contrast, (re)experiencing fear and grief during exposures are theorized to be integral to fear extinction and
habituation (Foa et al., 2007; Foa & Kozak, 1986; Jaycox & Foa, 1996). According to DT
theories, I would have expected individuals with lower levels of DT to attempt to suppress all
distressing emotions, helpful or not.
Levels of emotional engagement were rated by clinicians whereas baseline DT was selfrated by the participant. Since ratings (of DT and emotional engagement) were conducted by
different people, we might expect discrepancies in perceptions. However, even from varying
perspectives, self-rated DT was moderately and significantly related to therapist-rated emotional
engagement during exposure. This suggests a robust relationship, which could be potentially be
stronger if both variables were rated by the same person.
I would have initially predicted individuals with lower baseline DT would be more likely
to have lower ratings (e.g., scores of 1 or 2), but these results indicate all participants who
completed an exposure expressed at least a moderate level of emotion. Therefore, no participants
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demonstrated a minimal level of engagement, or “under-engagement” that could be considered
insufficient participation. This means regardless of baseline DT no participants appeared to be
fully impeded by emotional suppression or avoidance during their exposure. Across the span of
baseline DT, all participants who completed an exposure demonstrated an ability, at least in the
moment with guidance, to tolerate distressing emotions and persist with the experience of
imaginal exposure.
Hypothesis 2b: DT and details shared. Contrary to what was hypothesized, lower levels
of DT were significantly related to higher levels of detail shared during exposure. This indicates
participants with lower DT did not appear to be less open when sharing their experiences.
Instead, results suggested once these participants started to share their trauma narration via
exposure, they were more likely to describe all of the potentially overwhelming details in their
memories.
An alternative explanation for the relation between low baseline DT and higher levels of
detail shared could be participants with lower DT were less likely to filter out relatively
unimportant details related to the traumatic memory. Remembering and reliving details of the
traumatic experiences are theorized to be survival mechanisms as individuals remember details
to protect themselves against future traumatic experiences (McNally, 2005). Given the moderate
and significant correlation between emotional engagement and level of detail shared in exposure,
retaining a multitude of details could potentially contribute to individuals’ perceptions of feeling
unable to handle such distressing emotions. One of the purposes of the imaginal exposure
exercise is to “re-live” the experiences, recall the details, to associate them with less traumatic
experiences through the safe environment of the group. Therefore, these findings demonstrated
that individuals with lower DT were not less likely to engage in this critical exposure exercise.
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Instead, these individuals were more likely to engage by sharing a higher level of details, which
is indicative of engaged participation in the exposure exercise. Theoretically, it is possible those
who share more detail are inclined to greater opportunity for re-learning experiences by
beginning to associate previously feared trauma-related cues with a safer environment.
Internalizing Symptom Outcomes
Hypothesis 3a: DT improvement. As expected, DT increased from pre- to posttreatment. Lower levels of DT were also associated with greater improvement in DT from pre- to
post-treatment. This may be partly explained by those with lower levels of DT having more
“room to grow” in terms of DT scores. In other words, individuals with lower scores on the DTS
had more potential to improve these low scores.
It is also possible that those with lower DT who initially doubted their abilities to manage
distressing emotions, but persisted in treatment were more surprised by their treatment
completion than participants with higher DT. According to the self-efficacy theory (Bandura,
2010), these experiences may have been more novel for participants with lower baseline DT.
Theoretically, individuals with lower DT generally avoid engaging in distressing experiences
(e.g., Vujanovic et al., 2011). This would make the in-group exposure a more novel (newer)
experience than for individuals with higher perceived DT.
Emotional distress tolerance is often considered a “trait” variable. Given the changes in
DT from pre- to post-treatment, results suggest DT may be malleable via intervention, or is at
least associated with decreases in response to an exposure-based treatment.
Another considerable interpretation of these findings is that ratings of low DT could be
reflective of people who are “unsuccessful” at avoiding. For example, an individual may attempt
to evade their distress but have difficulty doing so. In contrast, individuals who can utilize
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avoidance as a coping strategy may rate themselves as having higher levels of DT, but this
perception may not be indicative of healthier coping strategies or true abilities to tolerate
distress. According to this potential interpretation, increases in DT from pre- to post-treatment
could still indicate growth during intervention in coping skills to tolerate distress.
Hypothesis 3b: DT and internalizing symptoms (PTSD & depression). Relations
between baseline DT and symptom outcomes (PTSD, depression) were not linear. Bivariate
scatterplots of both relations indicated similar patterns with a curve, or inflection point (i.e.,
slope changed direction) approximately at the midpoint (mean sum = 3) of the DTS scale. As
illustrated in Figures 6 and 8, the greatest improvement (highest change scores) were associated
with the lowest baseline DT scores. As baseline DT increased, the level of symptom
improvement decreased, until about the midpoint of the DT scale, when the growth appeared to
reach an asymptote, or level out. This phenomenon of non-linear relations between baseline DT
and symptom improvement, statistically modeled by linear and quadratic equations, was
statistically significant, and is hereby referred to as a “room to grow” model. Similar to the
pattern of improvement in DT, it appears the potency of engaging in a distressing
experience/exercise of exposure in treatment allows for a more unique learning experience for
individuals with lower DT. It is likely the level of engagement during exposure directly
contributed to symptom improvement.
For symptom improvement, change scores were most important since the focus of this
study is on treatment improvement. As demonstrated in Tables 6-8, post-treatment scores
demonstrated the same relations. Although change scores are influenced by pre-treatment
symptom scores, these were included and accounted for within the regression models. Therefore,
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the fact that pre-treatment DT still significantly and independently predicted change scores is
clinically important.
An alternative explanation for participant improvements could be regression to the mean;
However, we would not expect these variables to spontaneously change over time (e.g.,
untreated PTSD is typically chronic). Another explanation for improvements could be demand
effects, where participants rate post-treatment outcomes more favorably want to give the
clinicians and researchers positive feedback about the program; however, post-treatment
responses were not entirely favorable and participants were informed their responses would
remain anonymous and used for the benefit of future participants.
Robustness Checks
LOCF. Post-treatment scores were only available for participants who completed
treatment. Pre-treatment scores did not significantly differ for participants who completed
treatment compared to those who dropped out (Table 4). I used a Last Observation Carried
Forward (LOCF) model to explore if baseline DT remained significantly related to outcomes
when assuming no change for the participants who dropped out of treatment.
Pre-treatment DT significantly predicted change in DT using LOCF for all participants.
Pre-treatment DT did not significantly predict drop-out, but did predict DT change scores for
treatment completers. The initial hypotheses would have supported the notion that pre-treatment
DT could predict change in DT when the model included treatment completers (most of whom
increased in DT) and non-completers who were assumed to not change in DT. Given nonsignificant findings between baseline DT and dropout rates, this finding was actually unexpected.
Therefore, these results could suggest baseline DT is a highly powerful predictor of its own
change in treatment.
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For PTSD and depression change scores using LOCF, the models remained significant.
However, baseline DT did not significantly uniquely predict LOCF change scores for either
internalizing outcome variable after controlling for pre-treatment scores. Instead, pre-treatment
scores were predictive of all participants’ change scores. Although the lack of significance
between baseline DT and change scores for all participants was contrary to my hypothesis, this
finding is in line with the results from my first hypothesis, wherein baseline DT did not predict
drop-out. Given the lack of relation between baseline DT and participant completion, it is logical
that baseline DT would not predict change scores of 0 for participants who did not complete
treatment.
Emotional stability. In this study, on average ES increased from pre- to post-treatment.
The standard deviation for ES change was greater than the average change score. This reflects
that although the average change in ES was statistically significant, some participants’ ES
remained stable or decreased from pre- to post-treatment. The general trend of significant
increase in ES from pre- to post-treatment was not hypothesized given it is a measure of a traitlike characteristic of personality. However, these findings are consistent with previous literature
which demonstrated that personality characteristics, especially ES, can be altered as a result
treatment (Roberts et al., 2017). Although we did not have a control group for comparison, it
appears that completing the treatment likely contributed to an increase in perception of ES.
When ES was entered into the models of baseline DT and internalizing symptom
outcomes, the models remained significant. However, ES was not considered an independent
predictor of symptom change. This indicates that although ES may be a related and important
construct to consider when examining DT, the relation between baseline DT and symptom
changes in this study cannot be attributed to variability in personality level emotional stability, or
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neuroticism. Therefore, significant findings in the regression models can appropriately be
attributed to baseline DT.
Limitations and Future Directions
Of the 100 women who began this treatment, eight did not consent to the use of their
data, seven were missing pre-treatment data, and an additional three participants who completed
group were missing post-treatment data. Therefore, conclusions could only be drawn from
participants from whom we had data. Statistically, data appeared to be missing at random, but we
do not know if there was a unified theme amongst participants who decided not to consent for
their data to be used or those who were unavailable for post-treatment data collection.
Additionally, although the number of participants who began treatment met the pre-determined
recommendation for sample size (n = 85), the number of treatment completers with usable data
(n = 67) was less than recommended for adequate power. There were also analyses which
contained fewer participants. For example, less than 60% of the treatment completers (n = 41)
were surveyed about their desire to drop out of treatment. Therefore, this study is relatively
underpowered. Although findings should be reproduced due to the relatively low number of
participants, the relative lack of power may provide further support for the significance of the
findings, detected with this small sample size. Replication studies are recommended.
Given the treatment characteristics of providing services within a prison population,
results may not be generalizable to community treatment settings. However, these findings may
be generalizable to other correctional, rehabilitation, or institutional settings. Further research is
warranted within outpatient community settings. One concern related to exposure-based
treatment is the potential for increased substance use as symptoms may increase following
exposure (Ullman et al., 2013), which could potentially interfere with a client’s ability to
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successfully complete treatment and/or experience symptom reduction. Clients in this study did
not have the potential to relapse with substance use because of restricted access of substances in
a controlled environment. Therefore, this study was unable to draw conclusions about the use of
substances as coping strategies following exposure.
Other factors considered as variables to control for included demographics and trauma
history. Given this was an entirely female sample, there was no a priori hypothesis that any
demographic variable might impact these findings, especially since DT was not significantly
related to any demographic variables in this study. Given previous research suggesting an
interaction between gender and treatment completion (Tull et al., 2013) and the effectiveness
demonstrated by this short-term exposure-based therapy in a prison setting, this treatment and
related research should be replicated within incarceration facilities for men.
Although several other studies often explore characteristics of trauma exposure (e.g.,
frequency, duration, trauma type) and brief measures of trauma history were administered for
later groups of participants, anecdotally, the majority of participants endorsed a complex and
cumulative trauma history. Therefore, it was not expected that characteristics of trauma exposure
(e.g., trauma type, frequency, duration) would affect these results. However, future studies may
want to consider the relation between trauma exposure, DT, and treatment outcomes.
Future research would likely benefit from collecting data from participants who did not
complete treatment, including their motivations for dropping out of group. It would also be
beneficial to collect data from individuals who were eligible for treatment (e.g., incarcerated
women affected by histories of trauma) who opted to not enroll in the group treatment to serve as
a control group and further understand their motivations for not participating. Utilizing and
comparing results to a control group without a treatment could also account for demand
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characteristics and natural changes in responses due to time passage within the prison
environment. The current study did not obtain information about length of time in incarceration
prior to treatment. Studies have shown that adjusting to life in prison may be destabilizing and
symptoms may improve over time (e.g., Bridges et al., 2020). Therefore, it may be useful to
include length of time incarcerated in future studies to examine the intersection of other settingrelated factors.
As described in Results, qualitative responses were short and limited, which may be
attributable to space allotted, time commitment, or interest in elaborating. It is also important to
note that the qualitative descriptions of considerations for dropping out of the group were only
collected from individuals who completed treatment and were retrospective accounts of what
participants were thinking at an earlier time. It is possible that participants under-reported their
doubts and concerns regarding treatment and imaginal exposure after they completed treatment
and their fears subsided. There may have been more qualitative richness and elaboration of
concerns if they were assessed in real-time, before and during treatment. Future studies may
want to collect and explore qualitative responses from participants throughout the treatment
process to capture their fears and doubts while they are still active in treatment.
The research team responsible for the implementation of this treatment group theorized a
distinction between average level of emotion expressed and highest/peak level of emotion.
However, the new variable of average level of emotion expressed was marginally significantly
different from the old measurement of this variable and the peak emotion variable was highly
distinct from the previous variable. Given the high correlation of the two new variables, and lack
of statistical significance between this combination and the former variable, the new variables
were re-combined into a single category of emotional engagement. It is still possible that the two
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new variables could be representative of different constructs and therefore analyzed separately in
future studies when more participants have been rated using these new variables. Given the small
sample size, it was important to utilize as many ratings of emotional expression during the
exposures as possible.
Future studies may want to explore the participants’ subjective units of distress (SUDs)
during their exposures. Participants may have perceived their ability to tolerate emotional
distress during the exposure (i.e., state-level DT) during group differently than their baseline
ratings of general trait-level DT. There may also be a difference between clinician ratings of
emotion and client experiences, which may be warranted to explore.
Exposure is theorized to be the active mechanism of exposure-related trauma treatments
(e.g., Foa et al., 2007). Therefore, this study was exploring participants’ engagement in this
activity in relation to pre-treatment DT. It is recommended that future analyses explore if level of
engagement in exposure differentially relates to or predicts symptom improvement.
Similar to the theoretical confound in the literature, a temporal relationship between
trauma exposure and DT was not established in this study. It is unclear if those with pre-existing
low perceptions of DT relate to the development and maintenance of PTSD symptoms, or if
experiencing traumatic events could potentially impact a person’s perception of their DT,
especially as traumatic reactions may naturally increase (e.g., intrusive thoughts, flashbacks).
There were individual differences in baseline DT ratings, regardless of PTSD symptoms. This
indicates variability in the development of both PTSD and DT. While this study demonstrated
the predictive ability of DT in treatment outcome, it did not speculate about factors that may
impact the development or lack thereof of DT skills. Future studies may want to explore the
temporal relations between DT and PTSD.

49

Clinical Implications
Overall, participants’ perceptions of DT prior to treatment may be meaningful in
predicting outcomes for those who complete treatment. Although baseline DT did not predict
treatment completion in this study, lower levels of DT were significantly related to higher
emotional engagement during exposure and greater symptom improvement from pre- to posttreatment, as compared to those with moderate to high levels of DT. This pattern of findings
indicates a “room to grow” model: Those with low levels of DT may have the most potential and
opportunity to benefit from this novel experience of exposure-based treatment, which may
increase self-efficacy in addition to reduce internalizing symptoms. Participants with moderate to
high levels of DT at baseline still significantly improved in internalizing symptoms of PTSD and
depression from pre- to post-treatment, but not to the extent those with lower levels of DT did.
I predicted individuals with DT would be less likely to be able to engage in treatment.
Instead, they were more emotionally engaged, shared higher levels of detail, and demonstrated
the most symptom improvement. This is consistent with the notion that exposure therapies
provide “corrective” experiences for re-learning (e.g., Foa & Kozak, 1986). Most participants,
but especially individuals with lower levels of DT, were able to benefit from social learning in
this exposure-based group treatment. Social learning theory (Bandura, 1977, 2010) posits
individuals learn from complex interactions of social and environmental influences. In this group
treatment setting, participants with lower levels of DT could learn from other group participants,
who served as models. By witnessing other participants successfully engage in exposures,
participants could learn by example.
Individuals are most likely to learn from social modeling when they are attending to the
processes (Bandura, 1977, 2000); ratings of engagement during their own exposures suggest high

50

levels of treatment engagement. They were able to witness reinforcing processes (e.g.,
participants experiencing relief, praise from therapists) and therefore engagement in exposure
was reinforced. Social learning has also been shown to be most powerful in the context of
models who have been successful (e.g., participants who complete exposures), have status or
power (e.g., therapists), and when the individual observing may lack self-esteem (e.g., low
perception of their own abilities, perhaps low DT) and therefore seek alternative models of
behavior. Bandura (1977, 2010) also emphasizes the function of motivation and selfreinforcement, which was demonstrated by the qualitative responses that participants had a
strong desire to reduce their internalizing symptoms.
It is also important to note these findings remained significant after controlling for
general emotionality (ES). This robustness highlights DT as a unique concept beyond everyday
levels of emotions, especially as baseline DT predicted more intense levels of emotional
engagement during the context of exposures in treatment. Although I initially hypothesized
participants with lower DT would be least likely to engage in and therefore experience symptom
reduction from treatment, it appeared they were the participants who were the most emotionally
expressive during exposure and (most likely relatedly) benefitted the most from completing
treatment.
Most notably, this study demonstrates exposure-based therapies are acceptable to
individuals with symptoms of PTSD, depression, and low levels of DT. These findings directly
address concerns from clients and therapists about traumatized clients’ ability to handle the
distressing experience of exposure-related exercises. This study provided evidence of a relatively
low dropout rate from this exposure-based treatment. Even in the context of prison, participants
with low levels of DT who opted to enroll in and complete treatment were highly engaged in the
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treatment and demonstrated significant improvements in symptom reduction within 8-weeks.
Therefore, those theoretically most at risk for not benefitting from treatment demonstrated the
greatest gains from participating in treatment. This study provides support for offering exposurebased treatments to incarcerated women with a wide range of baseline DT.
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Appendix
Tables
Table 1
Demographics
Variable
Age
Ethnicity
Hispanic/Latina
Not Hispanic/Latina
Race
White
African American
Native American
Other
Marital status
Married
Divorced
Single
Dating, not married
Other
Number of children
Previous therapy
Yes
No
Note: n = 85

M (SD) or n (%)
31.55 (8.19)

Test Statistic for Completers
v. Non-Completers
t(82) = -1.41, p = .163
χ2(1) = 0.45, p = .505

2 (2.4%)
82 (96.5%)
χ2(3) = 1.36, p = .714
70 (82.4%)
3 (3.5%)
7 (8.2%)
4 (4.7%)
χ2(4) =3.87, p = .424
23 (27.1%)
21 (24.7%)
23 (27.1%)
11 (12.9%)
7 (8.2%)
2.55 (1.67)
62 (74.1%)
22 (24.9%)

t(83) = -0.05, p = .960

χ2(2) = 0.01, p = .939
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Table 2
Descriptive Statistics for Pre-treatment Variables
Total Sample
Completers
N = 85
n = 70
M (SD) or n (%) m (SD) or n (%)

Non-Completers
n = 15
m (SD) or n (%)

Test Statistic for
Completers v. NonCompleters

Pre-Treatment
DT
2.72 (0.89)
2.74 (0.88)
2.60 (0.97)
t (83) = -0.59, p = .559
ES
3.07 (1.54)
3.13 (1.56)
2.79 (1.46)
t (82) = -0.76, p = .451
PTSD
39.96 (19.77)
39.64 (19.74)
41.47 (20.56)
t (83) = 0.32, p = .747
PTSD - Clinical
56 (66%)
47 (67%)
9 (60%)
χ2 (1) = 0.28, p = .596
Depression
13.02 (6.51)
12.84 (6.43)
13.87 (7.05)
t (83) = 0.55, p = .584
Depression Clinical
36 (42%)
29 (41%)
7 (47%)
χ 2 (1) = 0.14, p = .709
Note: DT = Distress tolerance; ES = Emotional stability; Clinical = Percentage of participants above the clinical cut-off scores (PTSD:
PCL-5 ≥ 33; Depression: PHQ ≥ 15)

65
65

Table 3
Correlation Matrix of Pre- and Post-treatment and Change Scores for Predictor and Outcome Variables
1
1. DT Pre
2. PTSD Pre

2

3

4

5

6

8. PTSD Post
9. Dep Post

-.181

.228

.273*

-.208

.089

.227

10. ES Post

.265
*
-.598
***
-.397
**
-.320
**
.432
***

-.255
*
.483
***
.794
***
.525
***
-.466
***

-.287
*
.390
**
.497
***
.754
***
-.337
**

.499
***
-.295
*
-.493
***
-.404
**
.575
***

-.040

-.033

.201

-.006

.285
*
.210

.023

4. ES Pre
5. Emotion
6. Detail
7. DT Post

11. DT Change
12. PTSD Change
13. Dep Change
14. ES Change

8

9

10

11

12

13

--.421
***
-.402
***
.582
***
-.359
**
-.244
*
.356
**
-.175

3. Dep Pre

7

-.743
***
-.616
***
.280
*
-.026

--.567
***
.292
*
-.008

-.019

-.043

.195

.265*

.343
**
-.202

--.326
**
-.094

-.406
***
-.154

-.229

--

-.013

-.081

-.391
**
-.470
***
.460
***
.536
***
.225

-.257
*

--

-.177
.009

.281
*
-.075

-.680
***
-.540
***
-.177
-.442
***
-.215
.299
*

--.346
**
-.239

-.156

--

-.213

.102

-.426
***
.109

-.033

.552
***
.530
***
-.455
***

-.422
***

-.613
***
-.611
***

--.391
**

Note: *p < .05; **p < .01, ***p < .001; DT = Distress Tolerance; Dep = Depression; ES = Emotional Stability; Emotion = Level of
emotional engagement during exposure; Detail = Level of detail shared during exposure; n = 85 for 1 – 4; n = 67 for 5 – 14.
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Table 4
Comparing Pre- and Post-treatment Scores Among Program Completers
Pre-treatment
Post-treatment
Change
Test Statistic for PreVariable
M (SD)
M (SD)
M (SD)
to Post-Treatment
DT
2.71 (0.88)
3.53 (0.84)
0.82 (0.97)
t (66) = -6.86, p < .001
PTSD
39.79 (20.06)
15.36 (13.60)
-24.43 (21.93)
t (66) = 9.12, p < .001
Dep
12.94 (6.52)
5.79 (4.73)
-7.15 (6.93)
t (66) = 8.44, p < .001
ES
3.05 (1.54)
4.48 (1.39)
1.43 (1.47)
t (66) = -7.94, p < .001
Note: n = 70; DT = Distress Tolerance; PTSD = Posttraumatic Stress Disorder; Dep = Depression; ES = Emotional Stability
Table 5
Regression Models of Pre-treatment DT and Treatment Engagement Variables
Outcome
Emotional engagement
Step 1

Predictor

B (SE)

β, p

Model F, R2
F (1, 68) = 10.06, p = .002, R2 = .129

DT pre

-0.25 (0.08)

-0.36, p = .002
F (2, 67) = 8.66, p < .001, R2 = .21

Step 2
DT pre
-1.38 (0.45)
DT pre squared 0.20 (0.08)

-1.97, p = .003
1.63, p = .013

Details shared

F (1, 52) = 4.11, p = .048, R2 = .07

DT pre
-0.22 (0.10)
-0.27, p = .048
Note: n = 69; DT = Distress Tolerance; pre = pre-treatment; ES = Emotional Stability
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Table 6
Regression Models of Pre-treatment DT and DT Post-treatment and Change Scores
Outcome
DT post
Step 1

Predictor

B (SE)

β, p

Model F, R2
F (1, 65) = 9.43, p = .003, R2 = .13

DT pre

0.34 (0.11)

0.36, p = .003
F (2, 64) = 6.80, p = .002, R2 = .18

Step 2
DT pre
DT pre squared

-0.86 (0.62)
0.21 (0.11)

-0.90, p = .175
1.28, p = .057

DT change
Step 1

F (1, 65) = 36.25, p < .001, R2 = .36
DT pre

-0.66 (0.11)

-0.60, p < .001

Step 2

F (2, 64) = 20.78, p < .001, R2 = .39

DT pre
-1.86 (0.62)
-1.68, p = .004
DT pre squared
0.21 (0.11)
1.10, p = .057
Note: n = 66; DT = Distress Tolerance; Pre = pre-treatment; ES = Emotional Stability
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Table 7
Regression Models of Pre-treatment DT and PTSD Post-treatment and Change Scores
Outcome
PCL post
Step 1

Predictor

B (SE)

β (p)

F (1, 65) = 2.56, p = .114, R2 = .04
PCL pre

0.13 (0.08)

0.20, p =.114)
F (2, 64) = 1.49, p = .234, R2 = .04

Step 2
PCL pre
DT pre

0.10 (0.10)
-1.49 (2.27)

0.14, p = .338
-0.10, p = .512
F (3, 63) = 2.63, p = .058, R2 = .11

Step 3
PCL pre
0.11 (0.10)
DT pre
21.56 (10.83)
DT pre squared -4.08 (1.88)

0.17, p = .253
1.40, p = .051
-1.50, p = .033

PCL change
Step 1

F (1, 65) = 110.84, p < .001, R2 = .63
PCL pre

0.87 (0.08)

0.79, p < .001
F (2, 64) = 55.16, p < .001, R2 = .63

Step 2
PCL pre
DT pre
Step 3

Model F, R2

0.90 (0.10)
1.49 (2.27)

0.83, p < .001
0.06, p = .512
F (3, 63) = 40.49, p < .001, R2 = .66

PCL pre
0.89 (0.10)
0.81, p = .382
DT pre
-21.56 (10.82) -0.87, p = .051
DT pre squared 4.08 (1.88)
0.93, p = .033
Note: n = 66; DT = Distress Tolerance; PCL = Posttraumatic Checklist for DSM-5; Pre = pre-treatment; ES = Emotional Stability
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Table 8
Regression Models of Pre-treatment DT and Depression Post-treatment and Change Scores
Outcome
PHQ post
Step 1

Predictor

B (SE)

β (p)

Model F, R2
F (1, 65) = 5.24, p = .025, R2 = .08

PHQ pre

0.20 (0.09)

0.27, p = .025
F (2, 64) = 2.71, p = .074, R2 = .08

Step 2
PHQ pre
DT pre

0.18 (0.10)
-0.36 (0.73)

0.24, p = .081
-0.07, p =
.623
F (3, 63) = 4.38, p = .007, R2 = .17

Step 3
PHQ pre
DT pre
DT pre squared

0.22 (0.10)
9.37 (3.70)
-1.71 (0.64)

0.30, p = .026
1.74, p = .014
-1.81, p =
.009

PHQ change
Step 1

F (1, 65) = 85.77, p < .001, R2 = .57
PHQ pre

0.80 (0.09)

0.75, p < .001
F (2, 64) = 42.51, p = < .001, R2 = .57

Step 2
PHQ pre
DT pre

0.83 (0.10)
0.36 (0.73)

0.78, p < .001
0.05, p = .623
F (3, 63) = 33.48, p < .001, R2 = .62

Step 3
PHQ pre
DT pre

0.78 (0.10)
-9.37 (3.70)

0.74, p < .001
-1.19, p =
.014
DT pre squared 1.71 (0.64)
1.24, p = .009
Note: n = 66; n = 65; n LOCF = 84; DT = Distress Tolerance; PHQ = Patient Health Questionnaire-9; Pre = pre-treatment; ES =
Emotional Stability
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Table 9
Robustness Checks of Pre-treatment DT and Treatment Engagement Variables
Outcome
Emotional engagement
Step 1

Predictor

B (SE)

β, p

Model F, R2
F (1, 68) = 8.06, p = .006, R2 = .21

ES pre

-0.12 (0.05)

-0.33, p = .006
F (2, 67) = 5.54, p = .006, R2 = .14

Step 2
ES pre
DT pre

-0.06 (0.06)
-0.18 (0.11)

-0.15, p = .316
-0.26, p = .098
F (3, 66) = 5.95, p = .001, R2 = .21

Step 3
ES pre
-0.05 (0.06)
DT pre
-1.29 (0.47)
DT pre squared 0.19 (0.08)

-0.12, p = .432
-1.84, p = .007
1.58, p = .018

Details shared
Step 1

F (1, 52) = 0.21, p = .648, R2 = .00
ES pre

-0.03 (0.07)

-0.06, p = .648

Step 2

F (2, 51) = 2.77, p = .072, R2 = .10

ES pre
0.10 (0.09)
0.21, p = .241
DT pre
-0.34 (0.15)
-0.41, p = .025
Note: n = 69; DT = Distress Tolerance; Pre = pre-treatment; ES = Emotional Stability
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Table 10
Robustness Checks of Pre-treatment DT and DT Post-treatment and Change Scores
Outcome
DT post
Step 1

Predictor

B (SE)

β, p

Model F, R2
F (1, 65) = 8.69, p = .004, R2 = .12

ES pre

0.19 (0.06)

0.34, p = .004
F (2, 64) = 5.57, p = .006, R2 = .15

Step 2
ES pre
DT pre

0.11 (0.08)
0.22 (0.14)

0.19, p = .207
0.23, p = .136
F (3, 63) = 5.12, p = .003, R2 = .20

Step 3
ES pre
DT pre
DT pre squared

0.10 (0.08)
-0.96 (0.63)
0.21 (0.11)

0.19, p = .206
-1.02, p = .129
1.27, p = .057

DT change
Step 1

F (1, 65) = 6.18, p = .016, R2 = .09
ES pre

-0.19 (0.08)

-0.30, p = .016
F (2, 64) = 19.11, p < .001, R2 = .37

Step 2
ES pre
DT pre

0.11 (0.08)
-0.78 (0.14)

0.17, p =.207
-0.71, p < .001
F (3, 63) = 14.53, p < .001, R2 = .41

Step 3
ES pre
DT pre
DT pre squared

0.10 (0.08)
-1.96 (0.63)
0.21 (0.11)

0.16, p = .206
-1.78, p = .003
1.09, p = .057

DT Change (LOCF)
DT pre
-0.51 (0.10)
-0.49, p < .001
Note: n = 66; DT = Distress Tolerance; Pre = pre-treatment; ES = Emotional Stability

F (1, 83) = 26.60, p < .001, R2 = .24

72
72

Table 11
Robustness Checks for Pre-treatment DT and PTSD Post-treatment and Change Scores
Outcome
PCL post
Step 1

Predictor

B (SE)

β (p)

Model F, R2
F (2, 64) = 1.58, p = .214, R2 = .05

ES pre
PCL pre

-1.15 (1.46)
0.07 (0.11)

-0.13, p = .436
0.11, p = .519
F (3, 63) = 1.08, p = .365, R2 = .05

Step 2
ES pre
PCL pre
DT pre

-0.89 (1.65)
0.07 (0.12)
-0.87 (2.56)

-0.10, p = .592
0.10, p = .576
-0.06, p = .735
F (4, 62) = 1.99, p = .107, R2 = .11

Step 3
ES pre
PCL pre
DT pre
DT pre squared

-0.69 (1.61)
0.09 (0.11)
21.78 (10.91)
-4.034 (1.89)

-0.08, p =.669
0.13, p = .441
1.41, p = .050
-1.49, p = .037

PCL change
Step 1

F (2, 64) = 55.40, p = < .001, R2 = .63
ES pre
PCL pre

1.15 (1.46)
0.93 (0.11)

0.08, p = .436
0.85, p < .001
F (3, 63) = 36.46, p < .001, R2 = .64

Step 2
ES pre
PCL pre
DT pre

0.89 (1.65)
0.94 (0.12)
0.87 (2.56)

0.06, p = .592
0.86, p < .001
0.04, p = .735
F (4, 62) = 30.02, p < .001, R2 = .66

Step 3
ES pre
PCL pre
DT pre
DT pre squared

0.69 (1.61)
0.91 (0.11)
-21.78 (10.91)
4.03 (1.89)

0.05, p = .669
0.84, p < .001
-0.87, p = .050
0.92, p = .037
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Table 11 (Cont.)
Outcome
PCL change (LOCF)
Step 1

Predictor

B (SE)

β (p)

F (1, 83) = 53.69, p < .001, R2 = .39
PCL pre

0.69 (0.10)

0.63, p < .001
F (2, 82) = 26.86, p = < .001, R2 =
.40

Step 2
PCL pre
DT pre
Step 3

Model F, R2

0.67 (0.11)
-1.50 (2.33)

0.60, p < .001
-0.06, p = .522
F (3, 81) = 17.76, p < .001, R2 = .40

PCL pre
0.66 (0.11)
0.59, p < .001
DT pre
-6.08 (13.03)
-0.25, p = .642
DT pre squared 0.80 (2.24)
0.19, p = .722
Note: n = 66 for PCL post and change, n = 84 for LOCF; DT = Distress Tolerance; PCL = Posttraumatic Checklist for DSM-5; Pre =
pre-treatment; ES = Emotional Stability
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Table 12
Robustness Checks for Pre-treatment DT and PTSD Post-treatment and Change Scores
Outcome
PHQ Post
Step 1

Predictor

B (SE)

β (p)

Model F, R2
F (2, 64) = 2.72, p = .074, R2 = .08

ES pre
PHQ pre

-0.23 (0.45)
0.17 (0.11)

-0.08, p = .613
0.23, p = .125
F (3, 63) = 1.81, p = .155, R2 = .08

Step 2
ES pre
PHQ pre
DT pre

-0.16 (0.54)
0.16 (0.11)
-0.23 (0.87)

-0.05, p = .773
0.22, p = .142
-0.04, p = .792
F (4, 62) = 3.23, p = .018, R2 = .17

Step 3
ES pre
PHQ pre
DT pre
DT pre squared

-0.03 (0.52)
0.22 (0.11)
9.38 (3.73)
-1.71 (0.65)

-0.01, p = .952
0.30, p = .046
1.74, p = .014
-1.81, p = .010

PHQ change
Step 1

F (2, 64) = 42.52, p < .001, R2 = .57
ES pre
PHQ pre

0.23 (0.45)
0.83 (0.11)

0.05, p = .613
0.78, p < .001
F (3, 63) = 27.96, p < .001, R2 = .57

Step 2
ES pre
PHQ pre
DT pre

0.16 (0.54)
0.84 (0.11)
0.23 (0.87)

0.04, p = .773
0.79, p < .001
0.03, p = .792
F (4, 62) = 24.72, p < .001, R2 = .62

Step 3
ES pre
PHQ pre
DT pre
DT pre squared

0.03 (0.52)
0.78 (0.11)
-9.38 (3.73)
1.71 (0.65)

0.01, p = .952
0.74, p < .001
-1.19, p = .014
1.23, p = .010
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Table 12 (Cont.)
Outcome
PHQ change (LOCF)
Step 1

Predictor

B (SE)

β (p)

Model F, R2
F (1, 83) = 45.06, p < .001, R2 = .35

PHQ pre

0.62 (0.09)

0.59, p < .001
F (2, 82) = 22.30, p = < .001, R2 =
.35

Step 2
PHQ pre
DT pre

0.61 (0.10)
-0.18 (0.74)

0.58, p < .001
-0.02, p = .814
F (3, 81) = 15.10, p < .001, R2 = .36

Step 3
PHQ pre
DT pre
DT pre squared

0.58 (0.11)
-3.97 (4.32)
0.66 (0.74)

0.56, p < .001
-0.52, p = .316
0.49, p = .375

Note: n = 65; n LOCF = 84; DT = Distress Tolerance; PHQ = Patient Health Questionnaire-9; Pre = pre-treatment; ES = Emotional
Stability
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Figures
100 eligible
treatment
participants
8 did not
consent

92 consented

7 missing pretreatment data
85 pre-treatment
data

15 dropped out

70 completed
treatment

3 missing posttreatment data

67 in pre-post
analyses

Figure 1. Progression chart of participant flow.
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Figure 2. Proposed model of pre- and post-treatment relations between predictor and outcome
variables. A cross-lagged structural equation model was originally proposed to explore the
predictive power of pre-treatment distress tolerance on post-treatment distress tolerance and
post-treatment internalizing symptoms (PTSD, depression), controlling for pre-treatment
internalizing symptoms and emotional stability.

78

Figure 3. Pre- and post-treatment DT Scores. A LOESS line was added to fit 99% of data points.
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Figure 4. Pre-treatment DT and DT change scores. A LOESS line was added to fit 99% of data
points.
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Figure 5. Pre-treatment DT and post-treatment PTSD. A LOESS line was added to fit 99% of
data points.
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Figure 6. Pre-treatment DT and PTSD change scores. A LOESS line was added to fit 99% of
data points.
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Figure 7. Pre-treatment DT and post-treatment depression scores. A LOESS line was added to fit
99% of data points.
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Figure 8. Pre-treatment DT and depression change scores. A LOESS line was added to fit 99%
of data points.
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Figure 9. Distribution of baseline DT scores.
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Figure 10. Baseline DT and completion status. A box-and-whiskers-plot displays the distribution
of pre-treatment baseline scores for participants who completed treatment and those who did not.
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Figure 11. Pre-treatment DT & emotional engagement during exposure. This bivariate
scatterplot displays pre-treatment distress tolerance scores from the DTS and the level of
emotional engagement during the participant’s exposure. A LOESS line was added through 99%
of points.
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Figure 12. Pre-treatment DT & detail shared. This bivariate scatterplot displays pre-treatment
distress tolerance scores from the DTS and the level of detail shared during the participant’s
exposure. A LOESS line was added to fit 99% of points.
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Figure 13. Pre-treatment DT and DT change scores using LOCF. A LOESS line was added to fit
99% of data points.
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Figure 14. Pre-treatment DT and PTSD change scores using LOCF. A LOESS line was added to
fit 99% of data points.
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Figure 15. Pre-treatment DT and depression change scores using LOCF. A LOESS line was
added to fit 99% of data points.
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Measures
Distress Tolerance: DTS.
Please indicate the level to which you agree with each of the following statements.

1. ______ Feeling distressed or upset is unbearable to me.
2. ______ When I feel distressed or upset, all I can think about is how bad I feel.
3. ______ I can’t handle feeling distressed or upset.
4. ______ My feelings of distress are so intense that they completely take over.
5. ______ There’s nothing worse than feeling distressed or upset.
6. ______ I can tolerate being distressed or upset as well as most people.
7. ______ My feelings of distress or being upset are not acceptable.
8. ______ I’ll do anything to avoid feeling distressed or upset
.
9. ______ Other people seem to be able to tolerate feeling distressed or upset better than I can.
10. _____ Being distressed or upset is always a major ordeal for me.
11. _____ I am ashamed of myself when I feel distressed or upset.
12. _____ My feelings of distress or being upset scare me.
13. _____ I’ll do anything to stop feeling distressed or upset.
14. _____ When I feel distressed or upset, I must do something about it immediately.
15.

When I feel distressed or upset, I cannot help but concentrate on how bad the distress
actually feels.
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Emotional Stability (ES): TIPI.
Here are a number of personality traits that may or may not apply to you. Please write a number
next to each statement to indicate the extent to which you agree or disagree with that statement.
You should rate the extent to which the pair of traits applies to you, even if one characteristic
applies more strongly than the other.
Disagree
Strongly
1

Disagree
Moderately
2

Disagree
A Little
3

Neither Agree
or Disagree
4

Agree
5

Agree
A Little
6

Agree
Moderately
7

I see myself as:
1. ____
2. ____
3. ____
4. ____
5. ____
6. ____
7. ____
8. ____
9. ____
10. ___

Extraverted, enthusiastic
Critical, quarrelsome
Dependable, self-disciplined
Anxious, easily upset
Open to new experiences, complex
Reserved, quiet
Sympathetic, warm
Disorganized, careless
Calm, emotionally stable
Conventional, uncreative
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Engagement: Clinician Rating Form.
Date:______________ Group #: _______ID #: _____
Participant initials:
Attended session?
(yes/no)

1

2

3

Rater initials: _______
4

5

6

7

8

Shared this session?
(yes/no)
Total # participants this
session
Degree of group cohesion
this session
1 = none
2 = low
3 = med.
4 = high
5 = extreme
Degree of participant’s
average expressed emotion
this session
1 = none
2 = low
3 = med.
4 = high
5 = extreme
Degree of participant’s
highest expressed emotion
this session
1 = none
2 = low
3 = med.
4 = high
5 = extreme
Degree of personal details
shared by the participant
this session
1 = none
2 = low
3 = med.
4 = high
5 = extreme
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PTSD: PCL-5.
Below is a list of problems that people sometimes have in response to a very stressful experience.
Please read each problem carefully and then put a number from 1 (not at all) to 5 (extremely) in the
box to indicate how much you have been bothered by that problem in the last week.

Not at
all

A little
bit

1

2

Moderately

Quite
a bit

Extremely

3

4

5

In the past week, how much were you bothered by:
1.

Repeated, disturbing, and unwanted memories of the
stressful experience?

2.

Repeated, disturbing dreams the stressful
experience?

3.

Suddenly feeling or acting as if the stressful
experience were happening again (as if you
were actually back there reliving it)?

4.

Feeling very upset when something reminded
you of the stressful experience?

5.

Having strong physical reactions when
something reminded you of the stressful
experience (for example, heart pounding,
trouble breathing, sweating)

6.

Avoiding memories, thoughts, or feelings
related to the stressful experience?

7.

Avoiding external reminders of the stressful
experience (for example, people, places,
conversations, activities, objects or
situations)?
Trouble remembering important parts of the
stressful experience?

8.
9.

Having strong negative beliefs about yourself,
other people, or the world (for example, having
thoughts such as: I am bad, there is something
seriously wrong with me, no one can be
trusted, the world is completely dangerous)?
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10. Blaming yourself or someone else for the
stressful experience or what happened after it?
11. Having strong negative feelings such as fear,
horror, anger, guilt, or shame?
12. Loss of interest in activities that you used to
enjoy?
13. Feeling distant or cut off from other people?
14. Trouble experiencing positive feelings (for
example, being unable to feel happiness or
have loving feelings for people close to you)?
15. Irritable behavior, angry outbursts or acting
aggressively?
16. Taking too many risks or doing things that
could cause you harm?
17. Being “superalert” or watchful or on guard?
18. Feeling jumpy or easily startled?
19. Having difficulty concentrating?
20. Trouble falling or staying asleep?
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Depression: PHQ-9.

Over the last week, how often have you been bothered by
any of the following problems?

More than Nearly
Not Several half the
every
at all days
days
day
0

1

2

3

2. Feeling down, depressed, or hopeless

0

1

2

3

3. Trouble falling or staying asleep, or sleeping too much

0

1

2

3

4. Feeling tired or having little energy

0

1

2

3

5. Poor appetite or overeating

0

1

2

3

6. Feeling bad about yourself—or that you are a failure or
have let yourself or your family down

0

1

2

3

7. Trouble concentrating on things, such as reading the
newspaper or watching television

0

1

2

3

8. Moving or speaking so slowly that other people could
have noticed? Or the opposite—being so fidgety or
restless that you have been moving around a lot more than
usual

0

1

2

3

9. Thoughts that you would be better off dead or of
hurting yourself in some way

0

1

2

3

1. Little interest or pleasure in doing things

If you checked off any problems, how difficult have these problems made it for you to do your
work, take care of things at home, or get along with other people?

Not difficult at all

Somewhat difficult

Very difficult

Extremely difficult

□

□

□

□
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Participant Post-Treatment Feedback.
Did you consider dropping out of the group?
_____Yes
_____No
If Yes:
When did you consider dropping out (Select all that apply)?
_____Before the first session
_____After the first session
_____After the second session (before we started sharing stories)
_____Right after session 3 (first time sharing stories)
_____Half way through (sessions 3-5)
_____Towards the end (sessions 6-8)
_____Other: Please specify: ____________________________________________

Why did you consider dropping out?

What made you stay in this group?
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